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UNDER-REGULATED HEALTH CARE 

PHENOMENA IN A FLAT WORLD: 

MEDICAL TOURISM AND OUTSOURCING 

NICOLAS P. TERRY* 
INTRODUCTION 
When a politician hails the importance of a global economyl or 
a popularizer2 reports that our social and economic worlds have 
been flattened? patients, health care providers, and health lawyers 
may nod sagely in agreement. In their hearts, however, they know 
that health care is in denial. And they have good reason to be skep­
tical. Domestic health care seems resistant to market functioning 
and there is little evidence it is ready to take its place in the global 
economy. Doctors are subjected to state rather than nationallicen­
sure and discouraged from reaching beyond state or national bor­
ders with the Internet technologies used by every other industry. 
Hospitals are hampered by immigration policies when they seek to 
overcome physician shortages. Patients are denied access to drugs 
or treatments that are cheaper across nearby borders. 
Yet, health care is becoming more global in ways that patients 
and even some providers do not realize. Modern health care may 
still appear to be local, but how many patients know that, increas­
ingly, their prescription drugs are being tested on foreign popula­
tions, that there is little tracking of exactly where or by whom the 
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ies, Professor of Health Management & Policy, Saint Louis University, e-mail: 
terry@slu.edu. I thank Professor Margaret H. McDermott, SLU Law Library, and Nat­
alie Kean, SLU J.D. candidate, for their enthusiastic and valuable research assistance 
and Michael Henderson, SLU J.D.IM.H.A. candidate, for his editorial suggestions. 
Sandra Johnson, Tim Jost, Tom McLean, Kevin Outterson, and Kandis Scott were ex­
ceptionally generous with their time in making suggestions or commenting on earlier 
drafts. Copyright © 2007, Nicolas Paul Terry. All Rights Reserved. 
1. See, e.g., Address Before a Joint Session of the Congress on the State of the 
Union, 42 WKLY. COMPo PRES. Doc. 145, H17 (Jan. 31, 2006), available at http://www. 
gpoaccess.gov/sou/06sou.pdf ("With open markets and a level playing field, no one can 
out-produce or out-compete the American worker."). 
2. See Confusing Columbus, THE ECONOMIST, Mar. 31, 2005, at 77. 
3. THOMAS L. FRIEDMAN, THE WORLD Is FLAT: A BRIEF HISTORY OF THE 
TWENTY-FIRST CENTURY (2005). 
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history they just gave their doctor is being transcribed and 
processed, or that their CAT scan performed in a U.S. emergency 
room is analyzed a few minutes later by a radiologist on the other 
side of the world? 
This Article examines two intersecting phenomena: medical 
tourism and the outsourcing of health care goods and services. 
"Medical Tourism" (Part I) involves the resident of one state or 
country physically experiencing health care in another place. "Out­
sourcing" (Part II) involves care that appears domestic but has been 
dis aggregated to allow some components to be performed non-do­
mestically. Frequently the patient (or in the case of final benefi­
ciaries of a clinical trial, a domestic user of a subsequently approved 
drug) does not know that care has been outsourced. 
These two phenomena currently operate outside, and may be 
disruptive of, contemporary Western health care regulation. While 
health care, particularly in the U.S., is our most highly regulated 
industry, medical tourism and outsourcing appear to operate 
outside our traditional regulatory matrix. Having examined the ex­
tent to which this is an accurate intuition, this Article questions (in 
Part III) the extent to which we do or will enjoy increased trading 
of health services and addresses some of the issues that must be 
considered in approaching any regulatory questions posed by medi­
cal tourism and outsourcing. 
I. MEDICAL TOURISM 
The terms "medical tourism" and "health tourism" refer to 
treatments or surgery that have been planned in advance to take 
place outside a patient's usual place of residence.4 Originally, such 
tourism literally and rather quaintly applied to vacations at Euro­
pean spas. As communications and travel improved, medical tour­
ism was used, somewhat pejoratively, to describe the travel of 
patients from less-developed countries seeking superior health care 
in industrialized countries-a transfer that continues today with 
4. Atul D. Garud, Medical Tourism and its Impact on Our Healthcare, 18 NAT'L 
MED. J. INDIA 318, 318-19 (2005). 
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major medical centers in Europe5 and the U.S.,6 attracting high 
profit self-payers from other countries.7 
Today, however, it is more likely that the journey is reversed, 
as patients travel from industrialized countries to less-developed 
nations.8 Such patients are attracted by the lower costs of proce­
dures in less-developed countries, the opportunity to avoid their 
home country's health care rationing (e.g., waiting lists for certain 
surgical procedures),9 the need for a procedure still under regula­
tory review in their home country,lO or a belief in the healing poten­
tial of alternative procedures or medicines such as laetrile. ll 
Patients who fall ill while visiting abroad (e.g., "snowbirds") are 
generally not viewed as medical tourists. There are, however, some 
unplanned scenarios that raise similar issues to those raised by 
planned medical tourism-for example, the accident victim who 
5. See, e.g., Munich Airport, Doctors and Health Insurers, http://www.munich­
airport.de/ENIAreas/ConsumerIService/aerzte_und_Krankenkassen/index.h tml (last 
visited Mar. 18, 2007) (listing available medical services on the Munich International 
Airport website). 
6. See, e.g., Johns Hopkins Int'l, http://www.jhintl.net/jhi/english/default.asp (last 
visited Mar. 18, 2007); Philadelphia Int'l Medicine, http://www.philadelphiamedicine. 
com (last visited Mar. 18, 2007); Mayo Clinic, Services for International Patients, http:// 
www.mayoclinic.org/english/services.html(last visited Mar. 18, 2007). 
7. Steven Findlay, U.S. Hospitals Attracting Patients from Abroad, USA TODAY, 
July 22,1997, at lA, available at 1997 WLNR 3052799 (Westlaw) (reporting that gener­
ally there were increases in tourism traffic at leading U.S. medical centers, and that 
specifically, 6,000 medical tourists were treated at Johns Hopkins in 1996, and a pro­
jected 7,200 would be treated at the Mayo Clinic in 1997). 
8. See Peter Foster, Britons Flock to India for Fast, Cheap Surgery, DAILY TELE­
GRAPH (London), Aug. 27, 2005, at 4, available at 2005 WLNR 13494018 (Westlaw); 
Prithi Yelaja, India Offers Surgery in a Hurry, TORONTO STAR, June 17, 2006, at A01, 
available at 2006 WLNR 10481733 (Westlaw). 
9. See NHS Waiting Lists at 17-Year Low, BBC NEWS, Nov. 12,2004, http://news. 
bbc.co.uk/2/hilhealth/4006181.stm (noting September 2004 wait list of 856,600 people, a 
decline of 300,000 since March 1997). But see Brian Donelly, Patients Still Wait 234 
Days for Hip Operations, THE HERALD (Scotland), Apr. 24, 2006, available at http:// 
www.theherald.co.uk/news/60630.html(noting a delay of up to seven months for hip 
replacement surgery). 
10. Jean P. Fisher, Hip Patients Find Surgeons Overseas: Delay in FDA Approval 
for Hip Resurfacing Means Lost Opportunity at Duke, NEWS & OBSERVER (Raleigh, 
N.C.), Apr. 10,2006, available at 2006 WLNR 6007736 (Westlaw). 
11. See, e.g., Barron H. Lerner, McQueen's Legacy of Laetrile, N.Y. TIMES, Nov. 
15, 2005, at F5, available at 2005 WLNR 18424239 (Westlaw); Patients, Like King, Seek 
Hope in Mexico, FT. WAYNE J. GAZETTE (Fort Wayne, Ind.), Feb. 5, 2006, at A10, 
available at 2006 WLNR 2095649 (Westlaw); see also Rutherford v. United States, 616 
F.2d 455, 456-57 (10th Cir. 1980) (upholding the FDA's right to prohibit the importation 
of laetrile). 
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crosses a nearby national border to benefit from superior emer­
gency services.12 
Throughout the discussion that follows it bears remembering 
that there is limited data as to the number of medical tourists (and 
only slightly more regarding outsourcing). Stories about individuals 
forced to leave their own countries for better health care are media­
friendly and tempting cudgels for policy makers wishing to beat on 
aspects of health care, immigration, or other domestic policies. Af­
ter collecting and analyzing data on medical tourism from Canada 
to the United States, Steven Katz and colleagues note that the phe­
nomenon (and its assumed rationing cause) was used to support 
U.S. criticisms of universal coverage,13 Canadian attacks on the 
under-funding of that country's Medicare system, and Canadian 
proposals to increase the level of private participation in health care 
financing (for example, by re-capturing the private dollars spent 
south of the border).14 Notwithstanding the many political constit­
uents leveraging the tourism phenomenon, the same researchers 
found that, for the period of 1994-1998, the numbers of Canadian 
medical tourists seeking care in the U.S. was "almost indetectible" 
relative to domestic health care.15 
A. International Tourism 
Several regions and countries have explicitly established them­
selves as destinations for medical tourism.16 For example, the city 
of Bogota, Colombia promotes itself as a high-quality destination 
for medical tourists in Latin America.17 South African hospitals of­
fer "medical safaris," combining vacation with plastic surgery,18 
12. See, e.g., Guerrero v. Copper Queen Hosp., 537 P.2d 1329 (Ariz. 1975). 
13. See, e.g., Merrill Matthews, Jr., Americas: On a Bus to Bangor, Canadians 
Seeking Health Care, WALL ST. J., July 5, 2002, at A13, available at LEXIS. 
14. Steven J. Katz et aI., Phantoms in the Snow: Canadians' Use of Health Care 
Services in the United States, HEALTH AFF., May-June 2002, at 19, 27, available at http:// 
content.healthaffairs.orglcgilreprintl2113/19. 
15. Id. 
16. Ramola Talwar Badam, Foreign Surgeons Attract U.S. Patients, SEATTLE 
TIMES, Sept. 25, 2005, at AI, available at 2005 WLNR 15132786 (Westlaw) (reporting 
2004 figures for foreign patients treated in India (150,000), Singapore (200,000), and 
Thailand (600,000». 
17. Owain Johnson, Bogota Launches Health Tourism Project, BRIT. MED. J., July 
6, 2002, at 10, available at http://www.bmj.com!cgilcontentlfuI1l32517354/10/e. 
18. Medical Tourism: Need Surgery, Will Travel, CBC NEWS ONLINE, June 18, 
2004, http://www.cbc.ca/newslbackgroundlhealthcare/medicaltourism.html [hereinafter 
Medical Tourism]. 
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while Malaysian hospitals propose surgery in a resort setting.19 
Bumrungrad International HospitaPO in Bangkok, Thailand, at­
tracted 55,000 patients from the United States in 2005, 83 percent 
for non-cosmetic procedures.21 Mexico, often vilified in the highly 
politicized immigration debate as an exporter of undocumented pa­
tients, is developing a strong presence in offering low-cost dental 
services to patients from across its northern border,22 while, for in­
stance, Irish dental patients are offered cut-price cosmetic surgery23 
in "Hungary[,] the dental capital of the world. "24 
The largest number of press reports focus on medical tourism 
services provided in India,25 where the finance minister has urged 
his country to become a "global health destination,"26 and the head 
of one state, Kerala, declared 2006 to be "The Year of Medical 
Tourism."27 Analysts have predicted a $2.1 billion annual medical 
tourism revenue for India by 2012.28 Apollo Hospitals, the largest 
private health care group in Asia, has over seven thousand beds in 
thirty-eight hospitals (located in several countries, including India, 
Sri Lanka, Bangladesh, Ghana, Nigeria, Qatar, and Kuwait) and ac­
19. Eric Paul Erickson, Over The Ocean, Under the Knife: Vacationers Are Mak­
ing the Time to Work a Little Surgery into Exotic Trips, CHI. SUN-TIMES, Nov. 27, 2005, 
at 1C, available at 2005 WLNR 20723934 (Westlaw) (noting the rise of Penang as 
center, and the role of intermediary Beautiful Holidays). See generally Beautiful Holi­
days, Welcome to Beautiful Holidays, http://www.beautiful-holidays.com (last visited 
Mar. 18, 2007). 
20. See generally Bumrungrad International, Welcome, http://www.bumrungrad. 
com (last visited Mar. 18, 2007). 
21. Unmesh Kher, Outsourcing Your Heart: Elective Surgery in India? Medical 
Tourism is Booming, and U.S. Companies Trying to Contain Health-Care Costs Are 
Starting to Take Notice, TIME, May 29,2006, at 44, 44 available at http://www.time.com! 
time/magazine/article/0,9171 ,1196429 ,00.html. 
22. Id. 
23. Kreativ Dental Clinic, Kreativ Dental Clinic Tours Ireland, http:// 
www.kreativdentie (last visited Mar. 18, 2007). 
24. Victoria Colliver, Dental Work Too Expensive? Go Overseas, S.F. CHRON., 
Apr. 5, 2006, at AI, available at 2006 WLNR 5689178 (Westlaw). 
25. See, e.g., K. V. Prasad, Gearing Up for More Medical Tourists, THE HINDU 
(India-Online Ed.), Jan. 31, 2006, http://www.hindu.com/2006/01l31/stories/2006013111 
110100.htm; Americans and Europeans Are Trekking to India for Surgery, According to 
Bloomberg Markets Magazine; 'Medical Tourism' is a Growing Business in India, 
Bloomberg Markets Says, PR NEWSWIRE U.S., Jan. 27, 2005, available at LEXIS. 
26. Ray Marcelo, India Fosters Growing 'Medical Tourism' Sector, FIN. TIMES, 
July 2, 2003, at 10, available at http://yaleglobal.yale.edu/display.article?id=2016. 
27. Adrian Lee, Medical Tourism: A Hot Destination, DAILY EXPRESS (London), 
June 6, 2006, available at 2006 WLNR 9669509 (Westlaw). 
28. Garud, supra note 4, at 318-19; Marcelo, supra note 26; see also Want that 
Cardiac Surgery Done? Go to India!, INDIA ABROAD (N.Y. Ed.), June 24, 2005, at A40, 
available at 2005 WLNR 12004858 (Westlaw). 
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tively promotes its "International Patient Services."29 Apoll030 and 
Escorts Heart Institute and Research Centre,31 another major In­
dian tourist destination, even facilitate "virtual patient visits" for 
family members who are unable to physically accompany patients. 
Apollo reportedly treated 60,000 medical tourists between 2001 and 
the spring of 2004.32 This growing industry is supported by a num­
ber of U.S.-based intermediaries such as IndUShealth33 and Planet 
HospitaP4 that organize tourists' visits to India and other 
destinations.35 
B. Costs and Reimbursement 
The medical procedures offered by providers in India and 
other tourist destinations are considerably less expensive than in 
Western countries such as the United States or the United King­
dom. For example, in India, open-heart procedures cost about 10 
percent of the average industrialized-country price.36 
Historically, procedures that attracted medical tourists were 
those that were out-of-plan or otherwise would not be reimbursed 
by the patient's insurer or funded by a national health service. To­
day, there are some limited exceptions to this paradigm. Blue 
Cross and Blue Shield (U.S.) and BUPA (U.K.) now reimburse for 
29. Apollo Hosps. Group, Overview, http://apollohospitals.comJoverview.asp? 
Pgeuld=1066 (last visited Mar, 18, 2007); Apollo Hosps. Group, International Patients, 
http://www.apollohospitalgroup.comllnternational.htm (last visited Mar. 18, 2007); see 
also Medilux Healthcare Ltd., The Apollo Hospitals Group, Guide for Patients and 
their Doctors, available at http://www.mediluxhealth.netlpages/mediluxapollo.htm 
(follow the "Introductory Brochure" hyperlink under the heading "Downloads," at the 
bottom of the page) (last visited Mar. 18,2007); Superbrand 2003-2005, Apollo Hosps. 
Group, http://www.superbrandsindia.com/superbrands2003/apollo-hospitals/index.htm 
(last visited Mar. 18, 2007) (discussing the history of the Apollo Hospitals Group). 
30. Apollo Hosps. Group, Virtual Patient Visit, http://www.apollohospitals.comJ 
VirtuaIPatient.asp?Pgeuld=1066 (last visited Mar. 18, 2007). 
31. See generally Escorts Heart lust. & Research Centre Limited, International 
Patients, http://www.ehirc.comJinternational_patients/index.asp (last visited Mar. 18, 
2007). 
32. Medical Tourism, supra note 18; see also Jay Soloman, Traveling Cure: India's 
New Coup in Outsourcing, WALL STREET J., Apr. 26, 2004, at AI, available at LEXIS. 
33. IndUShealth, A New World of Care, http://www.indushealth.com (last visited 
Mar. 18, 2007). 
34. Planet Hosp., Medical Tourism World Wide, http://www.planethospital.com 
(last visited Mar. 18, 2007). 
35. Kher, supra note 21, at 46-47. 
36. See Garud, supra note 4, at 319. See generally The Globalization of Health 
Care: Can Medical Tourism Reduce Health Care Costs?: Hearing Before the S. Spec. 
Comm. on Aging, 109th Congo (June 27, 2006), available at http://aging.senate.gov/ 
hearin~detail.cfm?id=270728&. 
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treatments at some facilities in India.37 The same is also true of 
some of the new "mini-medical," low-cost, limited-benefit plans 
that increasingly attract U.S. consumers unable to afford traditional 
health insurance.38 
Medical tourism has even appeared on the radar of govern­
ment-funded health care as states seek to reduce their health care 
costs. For example, a bill introduced in the West Virginia House of 
Delegates in 2006 would have allowed employees covered by the 
state's Public Employees Insurance Agency to use Joint Commis­
sion International (JCI) accredited foreign hospitals, receive travel 
reimbursement for themselves and a companion, and participate in 
the savings with a cash rebate.39 
A different set of financing problems arises when the medical 
tourist looks to the destination country to fund his or her health 
care. The U.K. government has acknowledged that it "ha[s] never 
required the [N]ational [H]ealth [S]ervice to provide statistics on 
the number or nationality of overseas visitors treated" by the Na­
tional Health Service,40 or the costs involved in providing this treat­
ment (with cost estimates ranging from almost negligible sums to 
£200 million per year).41 The government has a website devoted to 
the issue,42 and has recently tightened its criteria for free care.43 
The first case of health tourism prosecuted by the National Health 
Service Counter Fraud Service was settled when an Egyptian busi­
nessman who had traveled to London specifically to get "free" Na­
tional Health Service treatment agreed to pay the £30,000 COSt.44 
37. Marcelo, supra note 26. 
38. Kher, supra note 21, at 46-47. Reducing costs with medical tourism has also 
been noted by employers. See Rick Martinez, A Passage to India for Surgery, NEWS & 
OBSERVER (Raleigh, N.C.), June 21, 2006, at A17, available at 2006 WLNR 10683034 
(Westlaw). 
39. H.B. 4359, 77th Leg., 2d Sess. (W. Va. 2006), available at http://www.legis. 
state.wv.uslBill_Text_HTMU2006_SESSIONS/RSlBillslhb4359%20intr.htm. 
40. 436 PARL. DEB., H.C. (6th ser.) (2005) 2745W (statement of Jane Kennedy, 
Sec'y of State for Health), available at http://www.publications.parliament.uk/palcm200 
506/cmhansrd/cm050912/text/50912127.h tm. 
41. See Are Health Tourists Draining the NHS?, BBC NEWS, May 14, 2004, http:// 
news.bbc.co.uk/2lhilhealth/3356255.stm. 
42. See The Dep't of Health (U.K.), Overseas Visitors, http://www.dh.gov.uk/ 
PolicyAndGuidance/lntemationaUOverseasVisitors/fs/en (last visited Mar. 18, 2007). 
43. National Health Service, 2004, S.1. 2004/614, art. 2, n 1-3 (U.K.), available at 
http://www.opsi.gov.uk/si/si2004/20040614.htm (amending National Health Service, 
1989 S.1. 1989/306, art. 1, 'II 2 (U.K.)). 
44. Health 'Tourist' Pays NHS £30,000, BBC NEWS, Apr. 6, 2005, http://news.bbc. 
co. ukl2lhilhealth/4415491.stm. 
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In the United States, the costs expended on patients who are 
undocumented aliens have become part of the immigration debate. 
The Emergency Medical Treatment and Active Labor Act (EM­
TALA) requires medical screening (effectively requiring free emer­
gency medical care), regardless of immigration or residency 
status.45 Some state legislation46 and common law tort duties47 
have similar effects. Federal legislators recently have engaged on 
the issue. Thus, the Medicare Prescription Drug, Improvement, 
and Modernization Act of 2003 (MMA)48 provides for reimburse­
ment of emergency health services furnished to undocumented 
aliens, resulting in large federal payments to border states.49 In 
contrast to such largesse, as of July 1, 2006, the Deficit Reduction 
Act of 2005 requires individuals to provide satisfactory evidence of 
citizenship or nationality when initially applying for Medicaid or 
upon a recipient's first Medicaid re-determination.50 Approxi­
mately fifty million low-income people are currently on Medicaid. 
Historically, self-attestation was sufficient. However, the new rules 
require more stringent documentation.51 California recently 
delayed implementation of the new requirement pending final fed­
eral guidance, risking the loss of federal funding. 52 Also, the Pov­
45. Emergency Medical Treatment and Active Labor Act, 42 U.S.c. § 1395dd 
(Supp. 2003). 
46. See, e.g., Guerrero v. Copper Queen Hosp., 537 P.2d 1329, 1331-32 (Ariz. 
1975). 
47. See, e.g., Wilmington Gen. Hosp. v. Manlove, 174 A.2d 135, 139-40 (Del. 
1961). But see, e.g., Guerrero, 537 P.2d at 1330-40 ("A private hospital has no duty to 
accept a patient ... unless a different public policy has been declared by statute or 
otherwise. "). 
48. Medicare Prescription Drug, Improvement, and Modernization Act of 2003 
(MMA), Pub. L. No. 108-173, § 1011, 117 Stat. 2066, 2432 (codified at 42 U.S.c. 
§ 1395dd); see also Dep't of Health & Human Servs., Ctrs. for Medicare & Medicaid 
Servs., Section 101 Provider Payment Determination, available at http://www.cms.hhs. 
gov/CMSforms/downloads/cms10130a.pdf. 
49. See generally Robert Pear, Payments to Help Hospitals Care for Illegal Immi­
grants, N.Y. TIMES, May 10, 2005, at All, available at 2005 WLNR 7325694 (Westlaw) 
(reporting payments of $70.8 million to California, $46 million to Texas, and $45 million 
to Arizona). 
50. Deficit Reduction Act of 2005, Pub. L. No. 109-171, § 6036, 120 Stat. 4 (codi­
fied at 42 c.F.R. § 435.407(j». 
51. See Letter from Dennis G. Smith, Dir., Ctrs. for Medicaid & State Opera­
tions, to State Medicaid Directors (June 9, 2006), available at http://www.cms.hhs.gov/ 
smdUdownloads/SMD06012.pdf. See generally Robert Pear, Medicaid Rules Get 
Tougher About Proof of Citizenship, N.Y. TIMES, June 5, 2006, at A4, available at 2006 
WLNR 9593565 (Westlaw). 
52. Rong-Gong Lin, II, State to Delay Benefit Rule: U.S. Law Set to Take Effect 
July 1 Requires ProofofCitizenship for Medi-Cali Coverage, Officials Fear Hasty Action 
Could Bar Legitimate Enrollees, L.A. TIMES, June 7, 2006, at B1, available at 2006 
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erty Law Center has filed a class-action lawsuit challenging the new 
procedures as violating both the Medicaid Act and due process 
protections.53 
As countries increase limitations on the provision of health 
care to nonresidents, medical professionals are placed in ethical 
jeopardy when a patient in need of care presents. For example, in 
the United Kingdom, apparent prohibitions to the provision of free 
medical care to asylum seekers have raised ethical questions. 54 It is 
unclear the extent to which health care workers are responsible for 
investigating the immigration status of patients before treating 
them.55 Similarly, those who staff emergency rooms in U.S. border­
state hospitals increasingly find themselves drawn into the docu­
mentation morass as pressure grows to ask the "immigration 
question. "56 
C. Interstate Tourism 
With geographically diverse major medical centers, and health 
care rationed by personal resources or managed care organizations 
rather than governmental policies, interstate medical tourism has 
not been a noticeable phenomenon in the United States. Emergen­
cies aside, patients typically seek treatment where they live and 
only occasionally travel to specialized providers in other states. Al­
though major medical centers do seek to attract patients from 
outside their own region or networks and routinely offer travel and 
accommodation services,57 these initiatives have not raised any sub-
WLNR 9721607 (Westlaw); see also Rong-Gong Lin, II, Tighter Medicaid Rules Put on 
Hold: A Federal Law Requires States to Now Verify Applicants' Citizenship, But Califor­
nia and Others Are Taking It Slow, L.A. TIMES, Nov. 17,2006, at B1, available at 2006 
WLNR 19953795 (Westlaw). 
53. Press Release, Sargent Shriver Nat'l Ctr. on Poverty Law, Suit Challenges 
New Law Requiring 50 Million People in Medicaid to Document Citizenship (June 28, 
2006) (on file with Western New England Law Review). Subsequently, a preliminary 
ruling was made against the plaintiffs on standing grounds. Bell v. Leavitt, No. 06 CV 
3520, 2007 U.S. Dist. LEXIS 11675 (N.D. Ill. Feb. 16, 2006). 
54. See, e.g., Edwin Borman, Health Tourism, 328 BRIT. MED. J. 60, 60-61 (2004), 
available at http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=314036&blobtype= 
pdf. 
55. See, e.g., Adrian O'Dowd, Health Tourism: The Dilemma for Nurses, NURS. 
ING TIMES, Nov. 4, 2003, at 32, 32-34, available at 2003 WLNR 10951050 (Westlaw). 
56. Julia Preston, Texas Hospitals' Separate Paths Reflect the Debate on Immigra­
tion, N.Y. TIMES, July 18, 2006, at AI, available at 2006 WLNR 12327709 (Westlaw) 
(quoting Leticia Martinez, a patient at Parkland Memorial in Dallas, Texas). 
57. See, e.g., Johns Hopkins Medicine, Hopkins USA, For Patients, http://www. 
hopkinsusa.orgIUSAIPatients/default.asp (last visited Mar. 18, 2007); Univ. of Tex., 
M.D. Anderson Cancer Ctr., International Center, http://www.mdanderson.org/ 
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stantiallegal or ethical concerns. Such major providers are likely to 
use a bricks-and-mortar franchising model and thus have a physical 
referral presence in other states.58 
Of growing interest, however, are online second-opinion ser­
vices, such as The Cleveland Clinic's Remote Medical Second 
Opinion service,59 which offer Internet-based consultations and po­
tentially will attract out-of-state patients to their bricks-and-mortar 
services. The Cleveland Clinic's service seeks to abide by state li­
censure laws and specifically exc1udes60 the provision of services in 
states that have highly restrictive rules as to online consultations.61 
Second-opinion sites lack most of the vices seen in the online medi­
cal and prescribing services targeted by professional organizations, 
regulators, and prosecutors.62 They do share some of the opportu­
nistic characteristics of so-called "questionnaire" prescribing In­
ternet sites (where a prior relationship with the consulting physician 
is unlikely)63 and tend to rely on record review rather than physical 
examination (a common complaint about online "pill-mills").64 
However, second-opinion "services tend not to get involved in pre­
scribing, and their record review process furthers continuity of care 
by involving, or at least copying their opinions to, the patient's ex­
departments/IPC (follow the "Patient Services" hyperlink, then the "Patient Travel Ser­
vice" hyperlink) (last visited Mar. 18, 2007). 
58. Thomas R. McLean, The Offshoring ofAmerican Medicine: Scope, Economic 
Issues and Legal Liabilities, 14 ANNALS HEALTH L. 205, 227 n.126 (2005); see, e.g., 
Mayo Clinic, Facts About Mayo Clinic in Arizona, http://www.mayoclinic.orgiabout/ 
arizona.html (last visited Mar. 18, 2007) (stating that Mayo Clinic Arizona offers ser­
vices in at least sixty-five different medical and surgical disciplines); Mayo Clinic, Facts 
About Mayo Clinic in Jacksonville, Florida, http://www.mayoclinic.orgiaboutl 
jacksonville.html (last visited Mar. 18, 2007) (stating that Mayo Clinic Jacksonville has 
over 306 physicians and over 4,378 allied health staff). 
59. See generally Cleveland Clinic, Welcome to MyConsult, My Consult Services, 
http://www.eclevelandclinic.orgimyConsuItHome (last visited Mar. 18, 2007); Partners 
HealthCare System, Inc., Partners Online Specialty Consultations, https:l!econsults. 
partners.org (last visited Mar. 18, 2007). 
60. Cleveland Clinic, Remote Medical Second Opinion Frequently Asked 
Questions, www.eclevelandclinic.orgiproductHome.jsp?productId=standard (follow the 
"View Remote Medical Second Opinion Frequently Asked Questions" hyperlink, then 
the "Is the eCleveland Clinic MyConsult remote second opinion service available in 
every state?" hyperlink) (last visited Mar. 18, 2007). 
61. See, e.g., OR. REV. STAT. ANN. §§ 677.135, 677.137 (West 2006). 
62. See Nicolas P. Terry, Prescriptions sans Frontieres (or How I Stopped Worry­
ing about Viagra on the Web but Grew Concerned about the Future of Healthcare Deliv­
ery), 4 YALE J. HEALTH POL'y L. & ETHICS 183, 258-59 (2004) [hereinafter Terry, 
Prescriptions sans Frontieres]. 
63. /d. at 259. 
64. Id.; see infra text accompanying note 194. 
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isting physician."65 Arguably, physical examination of "the patient 
is less important in second opinion consultation cases, where most 
of the analysis flows from review of blood work, scans, and pathol­
ogy tests" and focuses on treatment options rather than initial 
diagnosis.66 
International travel to avoid legal restrictions on types of 
health care is relatively rare, although not unknown as, for exam­
ple, in the case of foreign parents leveraging unregulated embryo 
gender identification in the United States.67 However, a number of 
medical tourists do travel or seek to travel outside their own states 
to benefit from more favorable socio-medical policies governing 
death and dying. Recall, for example, the well-known Busalacchi 
case.68 Christine Busalacchi was an accident victim who had en­
tered a permanent vegetative state. Her father and guardian 
wished to move her from a Missouri rehabilitation center to a Min­
nesota facility. Missouri sought to block her transfer in part be­
cause of a suspicion that her guardian was attempting to leverage 
the allegedly less stringent requirements in Minnesota for removal 
of feeding tubes. The Missouri Court of Appeals remanded the 
case to the trial court for further evidentiary hearings on the guard­
ian's burden "to provide a reasonable basis for the need to move 
Christine to another jurisdiction other than a desire to avoid the 
laws of Missouri."69 The majority opinion stated, "[W]e will not 
permit [the] guardian to forum shop in an effort to control whether 
Christine lives or dies."70 However, Judge Smith, dissenting, 
pointed out that, "Minnesota is not a medical or ethical waste­
land. . . . There is a parochial arrogance in suggesting, as the State 
does, that only in Missouri can Christine's medical, physical and le­
gal well being be protected or that only here will her best interests 
be considered."71 
65. Terry, Prescriptions sans Frontieres, supra note 62, at 259; see, e.g., Daniel 
Costello, Virtual Second Opinions, L.A. TIMES, Dec. 30, 2002, at F1, available at 2002 
WLNR 12412963 (Westlaw). 
66. Terry, Prescriptions sans Frontieres, supra note 62, at 259; see, e.g., Tara 
Parker-Pope, Virtual Second Opinions: When the Web Can Be Better than Seeing a Local 
Doc, WALL ST. J., Aug. 12, 2003, at D1, available at LEXIS. 
67. Carla K. Johnson, u.s. Sex-Selection Clinics Attract Foreigners, SEATTLE 
TIMES, June 15, 2006, at A18, available at 2006 WLNR 10391157 (Westlaw). 
68. In re Busalacchi, No. 59852, 1991 WL 26851 (Mo. Ct. App. Mar. 5, 1991), later 
proceedings at No. 73677, 1991 Mo. LEXIS 107 (Mo. Oct. 16, 1991). 
69. Id. at *5. 
70. Id. at *5, *9-10. 
71. [d. at *10. 
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Similar issues intrude into the assisted-suicide debate. Switzer­
land and the Netherlands have less restrictive laws than other Euro­
pean states or the United States.72 Swiss law only makes assisting 
suicide illegal when there is "self-interested motivation."73 Since 
1998, Dignitas,74 a Swiss non-profit relying on its avowed policy of 
"altruism," has reportedly provided accommodations and the nec­
essary life-ending barbiturates for more than 450 European sick or 
elderly "tourists" who have traveled to Switzerland to end their 
lives.75 In spite of concerns voiced (and even criminal investiga­
tions by police)76 in the deceased's countries of origin,77 Swiss legis­
lators have refused to revisit their law.78 
Oregon's Death with Dignity Act (ODWDA)79 is the only U.S. 
analog to these more liberal and potentially tourist-attracting re­
gimes.80 ODWDA "exempts from civil or criminal liability state­
licensed physicians who, in compliance with the specific safeguards 
in [the statute], dispense or prescribe a lethal dose of drugs upon 
the request of a terminally ill patient."81 In Gonzales v. Oregon,82 
the United States Supreme Court rebuffed an attempt by the U.S. 
Attorney General to use an interpretation of the federal Controlled 
72. Switzerland, unlike the Netherlands, is not a member of the European Union. 
See European Union, External Relations, EU's Relations with Switzerland, http://ec. 
europa.eu/commlexternal_relations/switzerland/intro/index.htm (last visited Mar. 18, 
2007). However, the "interstate" description used herein is appropriate given the coun­
try's close relationship with the Union and the bilateral treaties between the parties that 
provide for, e.g., freedom of movement of persons. See generally id. 
73. Dignitas: Swiss Suicide Helpers-"Live with Dignity, Die with Dignity" Is the 
Slogan of the Swiss Charity, BBC NEWS, Apr. 15, 2003, http://news.bbc.co.uk/2lhi/ 
healthl2948665.stm [hereinafter Dignitas: Swiss Suicide Helpers]. 
74. Dignitas, http://www.dignitas.ch (last visited Mar. 18, 2007). 
75. See generally Dignitas: Swiss Suicide Helpers, supra note 73; Dignitas: Swiss 
Suicide Helpers: Swiss Charity Dignitas Has Gained a Worldwide Reputation for Helping 
People with Chronic Diseases to End Their Lives, BBC NEWS, Jan. 24 2006, http://news. 
bbc.co.uk/2lhi/health/4643196.stm. 
76. See, e.g., Death Quiz For Family, MIRROR (London), June 3, 2006, at 15, avail­
able at 2006 WLNR 9510879 (Westlaw). 
77. See, e.g., In re Z (2004) EWHC 2817, [2005]1 W.L.R. 959, 2004 WL 2790666 
(Fam.) (U.K.) (refusing to order an injunction to restrain a competent person from 
traveling from England to Switzerland for assisted suicide). 
78. Hilary White, Switzerland Refuses to Alter Assisted Suicide Law to Nix Death 
Tourism, LIFESITENEWS.COM, June 2, 2006, http://www.lifesite.netlldnl2006/junl0606 
021O.html. 
79. OR. REV. STAT. §§ 127.800-127.995 (2005). 
80. California recently rejected similar legislation. Greg Lucas, Bill to Allow As­
sisted Suicide is Rejected: State Senate Committee Head Casts Key Vote Against Measure, 
S.F. CHRON., June 28, 2006, at AI, available at 2006 WLNR 11178674 (Westlaw). 
81. Gonzales v. Oregon, 126 S. Ct. 904, 911 (2006). 
82. Id. 
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Substances Act (CSA)83 to frustrate ODWDA.84 Unlike the Swiss 
assisted-suicide law, ODWDA specifically discourages medical 
tourism by requiring Oregon residency.85 Critics argue, however, 
that in practice, the residency determination is delegated to doctors 
and that it fails to pose a major barrier to nonresidents.86 
Any interstate assisted-suicide debate is likely to pale in com­
parison with the future legal landscape relating to abortion. Not­
withstanding the controversies that Roe v. Wade 87 and its progeny 
sparked, these decisions essentially provided a national ceiling on 
legal disincentives to pregnancy terminations, and as a result, 
should have reduced abortion-related tourism. However, this state 
of affairs would change rapidly if the Supreme Court takes the bait 
offered by a highly restricive state abortion statute88 and reverses 
Roe, particularly as some states will have passed "trigger laws" ban­
ning abortion upon Roe's demise.89 
Of course, federally guaranteed legal equivalence does not al­
ways create access to in-state health care. For example, South Da­
kota has only one abortion provider, a Planned Parenthood clinic 
staffed only once a week by doctors who travel from Minnesota.9o 
Mississippi and North Dakota have similar restrictive access is­
83. Controlled Substances Act, 21 U.S.c. §§ 801-904 (2000). 
84. Gonzales, 126 S. Ct. at 922-26. In contrast, a state ban on physician-assisted 
suicide has been held by the Court not to violate the Due Process Clause of the Four­
teenth Amendment. Washington v. Glucksberg, 521 U.S. 702, 734 (1997). 
85. OR. REV. STAT. § 127.805 (2005). A person may establish residency in Ore­
gon in the following ways: 
(1) Possession of an Oregon driver license; 
(2) Registration to vote in Oregon; 
(3) Evidence that the person owns or leases property in Oregon; or 
(4) Filing of an Oregon tax return for the most recent tax year. 
Id. § 127.860. 
86. See, e.g., The Consequences of Legalized Assisted Suicide and Euthanasia: 
Hearing Before the Subcomm. on the Constitution, Civil Rights and Property Rights of 
the S. Comm. on the Judiciary, 109th Congo (2006) (testimony of Rita L. Marker, Execu­
tive Dir., Int'! Task Force on Euthanasia and Assisted Suicide), available at http:// 
judiciary.senate.gov/testimony.cfm?id=1916&wiUd5377. 
87. Roe V. Wade, 410 U.S. 113 (1973). 
88. This was the apparent intent behind the South Dakota statute, H.B. 1215, 
2006 Leg., 81st Sess. (S.D. 2006)-however, the legislation was reversed by referendum. 
See, e.g., Stephanie Simon, South Dakota Scraps Abortion Ban, L.A. TIMES, Nov. 8, 
2006, at 16, available at 2006 WLNR 19353648 (Westlaw). 
89. Judy Peres, States Set Stage for Bans on Abortion, CHI. TRIB., June 12, 2006, at 
1, available at 2006 WLNR 10012408 (Westlaw). 
90. Evelyn Nieves, S.D. Abortion Bill Takes Aim at 'Roe', WASH. POST, Feb. 24, 
2006, at AI, available at 2006 WLNR 3182657 (Westlaw). 
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sues,91 suggesting that many patients are, in fact, forced to travel 
outside their own states for constitutionally protected medical 
treatment. 
Differences already exist between abortion laws across the fifty 
states. For example, twenty-six states require some form of paren­
tal consent or court authorization before a minor can terminate a 
pregnancy,92 suggesting an incentive for at-risk minors to travel out 
of state, and attracting controversial federal proposals to criminal­
ize those who transport such tourists or doctors who circumvent 
out-of-state barriers.93 If Roe is overturned, the vector between re­
strictive and unrestrictive states is likely to grow, creating a picture 
of legal and ethical confusion that will exceed even that in Austra­
lia, where diverse state laws,94 albeit generally liberal ones, create 
uncertainty for doctors and lawyers.95 
In a possible post-Roe world, the United States could also find 
itself visiting painful issues reminiscent of those experienced in the 
Republic of Ireland following its constitutional amendment banning 
abortions.96 There the temperature of the debate escalated follow­
ing successful legal challenges against restrictions on travel by wo­
men seeking abortions abroad.97 Roe's companion case, Doe v. 
Boiton,98 invalidated residency requirements in a Georgia abortion 
statute on the basis of the Privileges and Immunities Clause99 be­
cause a "contrary holding would mean that a State could limit to its 
91. /d. 
92. Crn. FOR REPROD. RTS., THE TEEN ENDANGERMENT Acr (H.R. 748; S.8, 
396,403): HARMING YOUNG WOMEN WHO SEEK ABORTIONS (2006), available at http:// 
www.crlp.org/pub_fac_ccpa.html. 
93. See, e.g., Child Custody Protection Act, S. 403, 109th Congo (2006). 
94. See Natasha Cica, Abortion Law in Australia, in 1998-99 AUSTRALIAN PAR. 
LIAMENTARY LIBRARY 1, available at http://www.aph.gov.au/library/pubs/rp/1998-99/99 
rp01.htm (describing the abortion laws of each Australian state and territory). 
95. See, e.g., Lachlan J de Crespigny & Julian Savulescu, Abortion: Time to Clar­
ify Australia's Confusing Laws, 181 MED. J. AUSTL. 201, 201-03 (2004), available at 
http://www.mja.com.au/pubJidissues/181_04_160804/dec10242_fm.pdf. 
96. Eighth Amendment of the Constitution Act, 1983 (Amend. No. 8/1983) (Ir.), 
available at http://www.irishstatutebook.ie/front.html (follow the "Acts of the 
Oreachtas" hyperlink, then the "1983" hyperlink, then the "Amendment No 811983­
Eighth Amendment of the Constitution Act, 1983" hyperlink) (last visited Mar. 18, 
2007). 
97. See, e.g., Att'y Gen. v. X [1992]1 LR. 1, 11 (Ir.); A. v. E. Health Bd., [1998]1 
LR. 464, 473 (Ir.), available at http://www.bailii.orglie/cases/IEHCI1997/176.html. 
98. Doe v. Bolton, 410 U.S. 179 (1973). 
99. U.S. CONST. art. IV, § 2, cl. 1. 
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own residents the general medical care available within its bor­
ders. "100 Justice Douglas famously wrote, 
Freedom of movement across frontiers in either direction, and 
inside frontiers as welI, was a part of our heritage. . . . It may be 
as close to the heart of the individual as the choice of what he 
eats, or wears, or reads. Freedom of movement is basic in our 
scheme of values.101 
Any state that tries to prevent its own residents from traveling to a 
more liberal abortion state will have to deal with that sentiment, 
along with a host of federal constitutional impediments, although C. 
Steven Bradford has argued that the issue is more nuanced than it 
might appear at first sight.102 
Such ethically complex and highly politicized issues aside, most 
interstate tourism tends to be a function of differing reimbursement 
rules or related state policies. In this area, European courts have 
faced some of the most challenging issues. Citizens of member 
states enjoy extensive freedom of movement within the European 
Union. For example, Council Directive 2004/58,103 which became 
100. Doe, 410 U.S. at 200. 
101. Kent v. Dulles, 357 U.S. 116, 126 (1958). See also Bigelow v. Virginia, 421 
U.S. 809 (1975), in which the Court held a Virginia statute, which was applied against a 
publisher who carried an advertisement for lawful abortion services available in New 
York, infringed his First Amendment rights. The majority opinion, authored by Justice 
Blackmun, contained the following dicta: 
The Virginia Legislature could not have regulated the advertiser's activity in 
New York, and obviously could not have proscribed the activity in that State. 
Neither could Virginia prevent its residents from traveling to New York to 
obtain those services or, as the State conceded, prosecute them for going 
there. Virginia possessed no authority to regulate the services provided in 
New York-the skills and credentials of the New York physicians and of the 
New York professionals who assisted them, the standards of the New York 
hospitals and clinics to which patients were referred, or the practices and 
charges of the New York referral services. 
Id. at 822-24 (citations omitted). 
102. See C. Steven Bradford, What Happens if Roe is Overruled? Extraterritorial 
Regulation of Abortion by the States, 35 ARIZ. L. REV. 87, 170 (1993) ("[T]he intuitive 
reaction against the extraterritorial application of abortion laws is not wholly justified 
by the case law."); cf Seth F. Kreimer, The Law of Choice and Choice of Law: Abor­
tion, the Right to Travel, and Extraterritorial Regulation in American Federalism, 67 
N.Y.U. L. REV. 451, 519 (1992) ("The right to travel to more hospitable environs could 
not, after the fourteenth amendment, be denied to former slaves seeking a better life. 
Under the same principles, even if Roe continues to erode or is ultimately overruled, 
that right cannot be denied to women seeking to choose their future."). 
103. Council Directive 2004/58/EC of 29 Apr. 2004 on the Right of Citizens of the 
Union and Their Family Members to Move and Reside Freely Within the Territory of 
the Member States, 2004 O.J. (L 229) 35 (EC), available at http://eur-lex.europa.eu/ 
LexUriServlsite/en/oj/2004/1_229/'-2292004062gen00350048.pdf; see also Council Direc­
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effective in April 2006, overhauled the existing patchwork of fed­
eral European laws (including the case law of the European Court 
of Justice)104 that permitted, for example, freedom of movement of 
workers and tourists. Under the new Directive, a citizen (and, in 
most cases, dependents and partners of a citizen) of a Union mem­
ber state has an almost unfettered right to reside in another mem­
ber state for three months.105 Thereafter, the person must be a 
worker (or self-employed) or have sufficient resources not to be­
come a burden on the social security system of the host state and 
have comprehensive health insurance.106 After five years this status 
converts into a right of permanent residence.107 Host states have 
only very limited rights to restrict freedom of movement based on 
public health grounds. lOS Strong safeguards for equal protection in, 
for example, access to employment or education, accompany the 
rights of residency.109 
The EU treaty severely limits federal control over the health 
systems of member states.110 However, the European Court of Jus­
tice (ECJ) has taken the position that state health systems cannot 
act so as to impede federally mandated freedom of movement of 
persons and services. All EU countries have universal coverage 
funded either by direct taxation or compulsory social insurance. 
However, they also have their own cost-containment policies, in­
cluding forms of rationing. In a series of cases dealing with outpa­
tient care and prescription fulfillment, the ECJ has refused to allow 
tive 2004/38IEC of 29 Apr. 2004 on the Right of Citizens of the Union and Their Family 
Members to Move and Reside Freely Within the Territory of the Member States, 2004 
0.1. (L 158) 77 (EC), available at http://www.lex.unict.itleurolabor/enldocumentation/ 
dirapprova te/dir(04 )-38en. pdf. 
104. See generally luliane Kokott, EU Citizenship-citoyens sans frontieres?, An­
nual European Law Lecture at the Durham European Law Institute (2005) (transcript 
available at http://www.dur.ac.uk/resources/deli/annualiecture/2005_DELI_Lecture. 
pdf). 
105. Council Directive 2004158, supra note 103, art. 6. 
106. Id. art. 7. 
107. Id. arts. 16-20. 
108. Id. art. 29. 
109. [d. art. 24. 
110. "Community action in the field of public health shall fully respect the re­
sponsibilities of the Member States for the organisation and delivery of health services 
and medical care." EUROPEAN COMM'N, THE INTERNATIONAL MARKET AND HEALTH 
SERVICES, REPORT OF THE HIGH LEVEL COMMITTEE ON HEALTH 5 (2001), available at 
http://ec.europa.eulhealth/ph_overviewlDocuments/key063n.pdf. 
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states to require prior authorization as a condition for reimbursing 
medical costs incurred in another member state. III 
The court has been somewhat more circumspect regarding im­
pediments to inpatient care provided elsewhere in the EU, permit­
ting requirements of prior authorization when the member state 
can provide the care without "undue delay."112 However, this qual­
ification must now be read subject to the recent Watts case.113 A 
75-year-old arthritic patient who had been wait-listed in England 
for hip replacement surgery, Mrs. Watts applied under the U.K.'s 
version of the EU's existing medical tourism rules, the so-called 
E112 scheme,114 but her application was refused. Subsequently, 
Mrs. Watts paid £3900 to have the procedure performed in France 
and then sought reimbursement from the National Health Service, 
which was refused. The EeJ interpreted EU treaty and legislative 
provisions regarding freedom of movement of persons and medical 
services to hold that: 
A refusal to grant prior authorization cannot be based merely on 
the existence of waiting lists intended to enable the supply of 
hospital care to be planned and managed on the basis of prede­
termined general clinical priorities, without carrying out in the 
individual case in question an objective medical assessment of 
the patient's medical condition, the history and probable course 
of his illness, the degree of pain he is in and/or the nature of his 
disability at the time when the request for authorization was 
made or renewed.u5 
As a result, EU health care systems will be forced to reimburse 
medical tourists who face "undue delay" in their own countries in 
light of their individual medical conditions, notwithstanding inter­
111. See, e.g., Decker v. Caisse de Maladie des Employes Prives, Case C-120/95, 
1998 E.c.R. 1-01831; Kohll v. Union des Caisses de Maladie, Case C-158/96, 1998 
E.C.R. 1-01931, 2 C.M.L.R. 879 (1998); MUller-Faure v. Onderlinge Waarborgmaat­
schappij OZ Zorgverzekeringen, Case C-385/99, 2003 E.C.R. 1-04509; Ludwig Leichtle 
v. Bundesanstalt flir Arbeit, Case C-8/02, 2004 E.C.R. 1-02641, available at http://eur­
lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:62002JO008:EN:HTML. 
112. See Geracrts-Smits v. Stichting Ziekenfonds, Case C-157/99, 2001 E.C.R. 1­
05473; Muller-Faure, Case C-385/99, 2003 E.c.R. 1-04509. 
113. Watts v. Bedford Primary Care Trust, Case C-372/04, 2006 E.C.R. 1-04325,3 
C.M.L.R. 5. 
114. Dep't of Health (U.K.), Going to an EEA Country or Switzerland in Order 
to Get Treatment, http://www.dh.gov.uk/en/Policyandguidance/Healthadvicefor 
travellers/index.htm (follow the "Getting medical treatment around the world" hyper­
link, then the "Getting treatment in EEA countries and Switzerland" hyperlink) (last 
visited Mar. 18, 2007). 
115. Watts, Case C-372/04, 2006 E.C.R. 1-04325, 3 C.M.L.R. 5. 
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nal budgetary considerations. That reimbursement obligation may 
also include travel costs if the state already pays for travel related to 
intrastate treatment. 116 Major increases in medical tourism follow­
ing Watts are likely to push EU states further along the road to a 
pan-European health care system.117 
D. Virtual Tourism 
For most Americans, the closest they will ever come to medical 
tourism is the "virtual" tourism they will experience, often unknow­
ingly, when they visit a foreign website offering medical informa­
tion or advice. The "medical" content that appears on such sites 
may be extremely valuable and may come from peer-reviewed 
sources,118 but too many sites contain information that is inaccu­
rate,119 dangerous,12o or contrary to accepted medical practice.121 
Other than urging "surfer-beware" and promoting information 
about high quality sites,122 there is little to be done to protect 
American virtual tourists against the harm they might suffer from 
relying on either domestic or foreign Web content. Formal ap­
proaches to assuring Internet content quality assurance are fraught 
with legal difficulties. "Public law intervention tends to be limited 
to obviously dangerous health content where government agencies 
can apply their traditional consumer-protection, drug-regulation, 
and fraud powers."123 Attempts at using more robust public regula­
116. Id. n 138-43. 
117. See, e.g., EU Chief Supports 'Health Market', BBC NEWS, Sept. 5, 2006, 
http://news.bbc.co.ukl2Ihilhealthl5315700.stm (reporting EU health Commissioner Mar­
kos Kyrianou's argument for single market in health care). 
118. See, e.g., WebMD, About WebMD-Editorial Policy, http://www.webmd. 
com/contentJarticie/60/67018.htm (last visited Mar. 18, 2007). 
119. See, e.g., James D. Cooper & Henry M. Feder Jr., Inaccurate Information 
About Lyme Disease on the Internet, 23 PEDIATRIC INFECTIOUS DISEASE J. 1105, 1107 
(2004) (noting that, of nineteen websites relating to lyme disease, nine gave inaccurate 
information concerning two or more topics). 
120. See generally Claire W. Anderson, A Call for Internet Pharmacies to Comply 
with Quality Standards, 12 QUALITY & SAFETY HEALTH CARE 86 (2003). 
121. See, e.g., Robert M. Wolfe et aI., Content and Design Attributes of Antivac­
cination Web Sites, 287 JAMA 3245, 3247-48 (2002). 
122. Cf HealthRatings.org, Ratings of Health Web Sites, http://www.health 
ratings.org (last visited Mar. 18, 2007). 
123. Terry, Prescriptions sans Frontieres, supra note 62, at 242; see, e.g., Press Re­
lease, FTC, FTC Charges Direct Marketers of Ephedra Weight Loss Products with 
Making Deceptive Efficacy and Safety Claims (July 1, 2003), available at http://www.ftc. 
gov/opa/2003/07 /ephedra.h tm. 
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tion or private litigation (even assuming jurisdiction and enforce­
ment) are likely to conflict with guarantees of free speech.124 
European institutions, including the European Commission, 125 
are enamored of self-regulatory ratings systems and codes of con­
duct126 often identified by "trustmarks."127 However, on balance, 
the "benefits to patients of self-regulatory codes are outweighed by 
the risks of overconfidence generated by valid trustmarks or out­
right fraud from the counterfeit ones."128 
II. OUTSOURCING 
Medical tourism (say, a U.S. resident who travels to India for a 
heart bypass) may be viewed as the complete outsourcing of health 
care.129 Traditionally, however, outsourcing has been viewed as the 
domestic export of non-core (or non-core competency) ancillary 
tasks.13° U.S. providers routinely use domestic outsourcing for non­
clinical tasks, everything from food service and gift shops to laundry 
and security. Today, some health care outsourcing is so well estab­
lished that the service providers are recognized as distinct health 
care entities; for example, "Pharmacy Benefits Managers" (PBMs) 
that health plans or employers use to control pharmaceutical 
costs.131 By 2005, one hundred U.S. health care providers (repre­
senting 6 percent of hospitals and 10 percent of beds) had fully out­
124. See generally Nicolas P. Terry, Cyber-Malpractice: Legal Exposure for 
Cybermedicine, 25 AM. J.L. & MED. 327 (1999). 
125. See, e.g., Europe's Information Soc'y Thematic Portal, Focusing on Quality, 
http://europa.eu.int/information_society/activities/health/policy_action_plan/quality_ 
criteria/index_en.htm (last visited Mar. 18, 2007). 
126. See, e.g., Internet Healthcare Coalition, eHealth Code of Ethics, http://www. 
ihealthcoalition.orglethics/ehcode.html (last visited Mar. 18, 2007); WebMD, Inc., Our 
Privacy Commitment to You, Health Internet Ethics, http://www.webmd.com!content/ 
pages/8/1761_50193.htm (last visited Mar. 18, 2007). 
127. Trustmarks or quality marks are (frequently trademarked) labels or graphi­
cal "marks" designed to signify compliance with criteria established by an independent 
mark holder. See, e.g., Health on the Net Found., HON Code of Conduct (HONcode) 
for Medical and Health Web Sites, The HONcode in Brief, http://www.hon.chIHON 
code/Conduct.html (last visited Mar. 18, 2007). 
128. Terry, Prescriptions sans Frontieres, note 62, at 243; see also Nicolas P. Terry, 
A Transatlantic Perspective on Regulating Health Information, 324 BRIT. MED. 1. 602, 
602-06 (2002); Nicolas P. Terry, Rating the "Raters": Legal Exposure of Trustmark Au­
thorities in the Context of Consumer Health Informatics, 2 J. MED. INTERNET RES. e18 
(2000), available at http://www.jmir.org/2000/3/e18. 
129. See Paul Malik, Insourcing and Outsourcing, 20 CAN. J. CARDIOLOGY 679, 
679 (2004), available at http://www.pulsus.com/CARDIOLl20_07/mali_ed.htm. 
130. See, e.g., id. 
131. See, e.g., Milt Freudenheim, Drugstores Fret as Insurers Demand Pills by 
Mail, N.Y. TIMES, Jan. 1,2005, at AI, available at 2005 WLNR 22598 (Westlaw). 
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sourced their information technologies (IT) functions. 132 Although 
late to the outsourcing model (compared to, for example, financial 
services), health care IT (HIT) outsourcing both within the U.S. 
and offshore is increasing rapidly, and already includes managed 
care call centers, systems design, and strategic planning.133 
As documented by Tom McLean, offshoring has a rich, com­
plex socio-political history, and it was only a matter of time before 
it caught health care services in its web.134 Non-domestic, offshore 
outsourcing was first embraced by U.S. IT companies and it has 
grown exponentially.B5 IT outsourcing has permitted the leverag­
ing of time zones to provide 24-7 support in addition to decreasing 
labor costs by using highly trained, but less expensive, foreign work­
ers for call centers. Not all foreign outsourcing goes to the Eastern 
Hemisphere. So-called nearshoring refers to outsourcing to coun­
tries that share geographic or cultural proximity with the source 
country. Increasingly, European countries nearshore to former 
Eastern bloc countries, while United States companies look to Ca­
nada or Ireland.136 
A. Offshore Data Processing 
Today, HIT are at the very core of health care. U.S. health 
care's tardy137 but rapidly accelerating investment in HIT, including 
HIPAA-mandated electronic transactions, error-reducing "process­
132. The HIT Report from KLAS: Successes and Challenges with Full IT Out­
sourcing, 4 ELEcrRONICHEALTHCARE 110, 110-16 (2005), available at http://www.long 
woods.comlproduct.php?productid=I7707&cat=401&page=1 (follow the "Download 
PDF" hyperlink). 
133. See, e.g., Harry Downs, Jr., Outsourcing and IT: Keeping Innovation In­
House, AHIP COVERAGE, Sept.-Oct. 2004, at 72; Susan Kirkpatrick, Using Information 
Networks as a Decision-Making Tool, J. HEALTHCARE RESOURCE MGMT., Nov. 1995, at 
21, 21-24; see also Alan Joch, Wiping the Slate Clean: Why Network Outsourcing is In, 
HEALTHCARE INFORMATICS, Jan. 1998, 81, 81-84. 
134. See generally McLean, supra note 58. 
135. See, e.g., Saritha Rai, India Becoming a Crucial Cog in the Machine at I.B.M., 
N.Y. TIMES, June 5, 2006, at C4, available at 2006 WLNR 9593509 (WestIaw) (reporting 
that IBM now has 43,000 employees in India, while continuing to make cuts in its U.S. 
workforce); see also Steve Lohr, Indian Outsourcer Says Big Profits Will Continue, N.Y. 
TIMES, Apr. 15, 2006, at C3, available at 2006 WLNR 6337512 (Westlaw) (reporting 
positive revenue and profits for Indian and U.S. companies' outsourcing operations in 
India). 
136. Geoffrey Nairn, New Contenders Jostle for Software Crown, FIN. TIMES 
(London), Dec. 1,2004, available at 2004 WLNR 12534333 (WestIaw). 
137. See generally Jeff Goldsmith et aI., Federal Health Information Policy: A 
Case of Arrested Development, HEALTH AFF., May-June 2003, at 44. 
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supporting" technologies, and electronic medical records,138 has co­
incided with unprecedented pressure to reduce costs. IT is not a 
health care industry core competency and has proved itself to be a 
prime candidate for offshoring. The administrative complexity and 
costs of U.S. health care are significant contributors to its higher 
prices relative to other countries. 139 HIPAA's "Administrative 
Simplification" has not delivered on expected cost-savings;140 off­
shoring its mandated electronic transactions processes to lower-cost 
IT countries might. 
In India, data entry costs are less than half of what they are in 
the United States.141 In fact, "Already half of the $20 billion U.S. 
medical transcription industry is outsourced" to other countries.142 
Billing, coding, data-clearing, claims processing, and electronic 
records data processing and storage follow. 
U.S. law extensively regulates the processing and storage of pa­
tient data, such as medical records and images, with regard to reten­
tion, integrity, confidentiality, and security. Although now 
supplemented by federal Medicare rules,143 state statutory rules 
generally continue to govern the length of time that providers must 
retain records and images.144 In addition, the AMA Code of Medi­
cal Ethics places an obligation on physicians "to retain patient 
records which may reasonably be of value to a patient" and urges 
physicians to take note of state and federal retention rules and ap­
plicable medical malpractice statutes of limitation.145 Similarly, 
federal regulations,146 Joint Commission on Accreditation of 
138. See generally Nicolas P. Terry, To HIPAA, a Son: Assessing the Technical, 
Conceptual, and Legal Frameworks for Patient Safety Information, 12 WIDENER L. REV. 
137 (2006) [hereinafter Terry, To HIPAA, a Son). 
139. Uwe E. Reinhardt et aI., U.S. Health Care Spending in an International Con­
text, HEALTH AFF., May-June 2004, at 10, 13-15. 
140. D'Arcy Guerin Gue with Randa Upham, The HIPAA Prescription for 
Healthcare-Why Isn't It Working?, HEALTH MGMT. TECH., Sept. 2004, at 34, 34, 36. 
141. Ed Silverman, It's a Small World After All: Outsourcing Makes Inroads, 
MANAGED CARE, June 2005, at 46, 48. 
142. Terry, To HIPAA, a Son, supra note 138, at 164; see David Lazarus, Looking 
Offshore: Outsourced UCSF Notes Highlight Privacy Risk, How One Offshore Worker 
Sent Tremor Through Medical System, S.F. CHRON., Mar. 28, 2004, at Al [hereinafter 
Lazarus, Looking Offshore), available at 2004 WLNR 7644456 (Westlaw). 
143. See, e.g., Condition of Participation: Medical Record Services, 42 C.F.R. 
§ 482.24(b)(1) (2005) ("Medical records must be retained in their original or legally 
reproduced form for a period of at least 5 years. "). 
144. See, e.g., N.M. STAT. ANN. § 14-6-2 (West 2003); LA. REV. STAT. ANN. 
§ 40:2144(F) (2001). 
145. CODE OF MEDICAL ETHICS E-7.05 (1994). 
146. 42 C.F.R. §§ 482.24(b), (c) (2006). 
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Healthcare Organizations (JCAHO) accreditation rules,147 and 
state licensure laws all impose duties of accuracy, completeness, leg­
ibility, and timeliness on the keeping of records.148 Some state stat­
utes prohibit the alteration of records,149 and expanding common­
law remedies for spoliation penalize their concealment or destruc­
tion.150 There is also authority for the proposition that keeping in­
adequate records can constitute common-law malpractice.151 The 
as yet unanswered question is how effective these domestic-facing 
regulatory models are in protecting U.S. patient data processed 
offshore. 
Concerns about the confidentiality and security of patient data 
being processed offshore were highlighted by two events in 2003. 
First, a medical transcriber in Pakistan, working for a subcontractor 
for the University of California at San Francisco, e-mailed the hos­
pital and threatened to distribute patient files on the Internet after 
the contractor allegedly failed to pay her. 152 Just a few weeks later, 
employees of the Indian office of another U.S. transcription com­
pany sent an anonymous e-mail to the company threatening to re­
147. JOINT COMM'N ON ACCREDITATION OF HEALTHCARE ORGS., 2005 CRITICAL 
ACCESS HOSPITAL STANDARDS, MANAGEMENT OF INFORMATION 14, available at http:// 
www.worh.orglpdCetc/Dec2/standards.pdf ("The medical record contains sufficient in­
formation to identify the patient; support the diagnosis/condition; justify the care, treat­
ment, and services; document the course and results of care, treatment, and services; 
and promote continuity of care among providers."). 
148. See, e.g., N.M. STAT. ANN. § 61-6-15(D) (West 2003) ('''Unprofessional or 
dishonorable conduct' ... includes ... (33) improper management of medical records, 
including failure to maintain timely, accurate, legible and complete medical records."); 
NEV. REV. STAT. ANN. § 630.3062-1 (LexisNexis 2005); WYo. STAT. ANN. § 33-26­
402(a)(xxvii)(G) (2005); Schwarz v. Bd. of Regents, 453 N.Y.S.2d 836 (N.Y. App. Div. 
1982); Nieves v. Chassin, 625 N.Y.S.2d 344 (N.Y. App. Div. 1995). 
149. See, e.g., NEV. REV. STAT. ANN. § 630.3062-2 (LexisNexis 2005). 
150. See, e.g., Keene v. Brigham & Women's Hosp., Inc., 786 N.E.2d 824 (Mass. 
2003) (upholding sanction of liability because of missing records); Rosenblit v. Zimmer­
man, 766 A.2d 749 (N.J. 2000) (canvassing various remedies and adopting independent 
tort remedy); cf Brown v. Hamid, 856 S.W.2d 51, 57 (Mo. 1993) ("The Missouri cases, 
statutes, and common law address a physician's duty to let the patient inspect and copy 
medical records. They do not create an independent duty to maintain medical records. 
To be sure, in another case, failure to maintain medical records may contribute to, or 
constitute, medical malpractice. . . . There is no need, in this case, to recognize an 
independent tort of negligent maintenance of medical records."). 
151. Thomas v. United States, 660 F. Supp. 216, 218 (D.C. Cir. 1987). 
152. David Lazarus, A Tough Lesson on Medical Privacy, Pakistani Transcriber 
Threatens UCSF Over Back Pay, S.F. CHRON., Oct. 22, 2003, at AI, available at 2003 
WLNR 8302881 (Westlaw); see also Lazarus, Looking Offshore, supra note 142. 
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lease medical records, but they were apprehended by police at a 
Bangalore Internet cafe.153 
HIPAA privacy (actually, confidentiality)154 and security ap­
plies only to a limited subset of health care entities,155 "a relatively 
narrow purview given the range of U.S. and offshore players likely 
to be involved in [medical data] processing."156 Notwithstanding, 
many of the U.S.-based data "extenders," such as outsourced radi­
ology or ICU monitors, likely will be "covered entities." Further­
more, U.S. or offshore data processors of Protected Health 
Information (PHI)157 are "business associates"158 of HIPAA "cov­
ered entities."159 As such, these contractual relationships must in­
corporate HIPAA limitations on data disclosure.16o 
U.S. records laws and HIPAA confidentiality and security ob­
viously apply to U.S. providers who use offshore data entry and 
processing.161 However, questions have been raised as to the extent 
to which such protections can be enforced against non-U.S. contrac­
tors.162 In 2004, Congressman Edward Markey formally questioned 
the sufficiency of offshore data protection. Responding, "then 
HHS Secretary [Tommy] Thompson admitted that his department 
failed to document the 'nature or content' of the contracts between 
covered entities and their business associates, or directly regulate 
153. David Lazarus, Extortion Threat to Patients' Records, S.F. CHRON., Apr. 2, 
2004, at A1, available at 2004 WLNR 7648210 (Westlaw). 
154. See generally Nicolas P. Terry & Leslie P. Francis, Ensuring the Privacy and 
Confidentiality of Electronic Health Records, 2007 U. ILL. L. REV. 681 [hereinafter 
Terry & Francis, Ensuring the Privacy and Confidentiality of Electronic Health Records]. 
155. 45 C.F.R. § 160.103 (2005). 
156. Terry, To HIPAA, a Son, supra note 138, at 164. 
157. 45 C.F.R. § 160.103 (defining "protected health information" as "individu­
ally identifiable health information," which includes "demographic information col­
lected from an individual, and: (1) Is created or received by a health care provider, 
health plan, employer, or health care clearinghouse; and (2) Relates to the past, pre­
sent, or future physical or mental health or condition of an individual; the provision of 
health care to an individual; or the past, present, or future payment for the provision of 
health care to an individual; and (i) That identifies the individual; or (ii) With respect to 
which there is a reasonable basis to believe the information can be used to identify the 
individual "). 
158. Terry, To HIPAA, a Son, supra note 138, at 164. 
159. Id. 
160. 45 C.F.R. § 164.504(c) (2005). 
161. For a useful survey of the data confidentiality and security issues and detail 
on legal reform in destination countries, see Barbara Crutchfield George & Deborah 
Roach Gaut, Offshore Outsourcing to India by U.S. and E. U. Companies: Legal and 
Cross-Cultural Issues That Affect Data Privacy Regulation In Business, 6 U.c. DAVIS 
Bus. L.J. 13 (2006). 
162. See, e.g., David Lazarus, Medical Charts Not All that Private, S.F. eHRON., 
June 8, 2003, at A1, available at 2003 WLNR 8241189 (Westlaw). 
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offshore business associates."163 Keen to protect their new HIT in­
dustries, offshore processing destinations such as India and Paki­
stan are attempting to reduce the vector between domestic and 
foreign data-source laws by improving legal protections for out­
sourced data processed within their borders.164 
B. Offshore Medical Services 
Information technologies are obviously highly portable. But 
other technology that enables portability affects the way clinical 
services may be provided. Specifically, technology facilitates the 
disaggregation (e.g., separating an assay from its interpretation)165 
of some heretofore unitary and exclusively professional tasks. Dis­
aggregation of professional tasks already has led to physician ex­
tenders, such as nurse practitioners and physician assistants. The 
technological mediation of health care enables data extenders. 
Faced with growing shortages in some physician specialties,166 the 
health care industry is leveraging this technology to outsource and 
even offshore some clinical tasks to data extenders. Radiology is 
already heavily offshored; pathology may soon follow, as may the 
already outsourced task of ICU monitoring.167 
The Leapfrog Group, the well-known health safety advocacy 
organization, has noted that mortality rates are significantly lower 
in hospital ICUs that are exclusively staffed with board-certified in­
tensivists.168 ICU demand is increasing dramatically, but at the 
same time, there is a shortage of both intensivists and pharma­
163. Terry, To HIPAA, a Son, supra note 138, at 165 (citing Letter from Tommy 
G. Thompson, Sec'y, U.S. Dep't of Health & Human Servs., to Edward J. Markey, 
Congressman, U.S. H. of Reps. 2 (June 14, 2004». 
164. See, e.g., IT Ministry Unveils Draft of Data Protection Act, DAILY TIMES 
(Pakistan), Nov.14, 2004, available at http://www.dailytimes.com.pk/default.asp?page= 
story _14-11-2004_pg7 _38. 
165. Robert M. Wachter, The "Dis-location" of u.s. Medicine-The Implications 
of Medical Outsourcing, 354 NEW ENG. J. MED. 661, 663 (2006). 
166. See, e.g., Raja Mishra, Radiology Work Shifts To Overnight, Overseas, Bos­
TON GLOBE, June 29, 2005, at AI, available at 2005 WLNR 10231496 (Westlaw) (noting 
shortages in Massachusetts of neurosurgery, anesthesiology, gastroenterology, cardiol­
ogy, orthopedics, and radiology specialists). See generally Richard A. Cooper et aI., 
Economic and Demographic Trends Signal an Impending Physician Shortage, HEALTH 
AFF., Jan.-Feb. 2002, at 140, available at http://content.healthaffairs.orglcgi/reprintl21111 
140.pdf. 
167. Rob Stein, Hospital Services Performed Overseas, WASH. POST, Apr. 24, 
2005, at AI, available at 2005 WLNR 6383494 (Westlaw). 
168. THE LEAPFROG GROUP, ICU PHYSICIAN STAFFING 1 (2007), available at 
http://www.leapfroggroup.orglmedia/file/Leapfrog-ICU _Ph ysician_Staffin~Fact_Sheet. 
pdf. 
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cistS.169 As a result, electronic outsourcing of ICU supervision170 is 
now common, with more than one hundred U.S. hospitals using re­
mote monitoring for their ICUSPl If reimbursement rules change, 
remote monitoring by home health care agencies likely will follow 
this trend. l72 There are no obvious practical reasons why such mon­
itoring cannot take place on the other side of the world. 
There is a critical shortage of radiologists practicing in the 
United States, leading to some three hundred U.S. hospitals now 
outsourcing their imaging.173 This is possible because of the sophis­
tication of modern Picture Archiving and Communication System 
networks. Again, outsourcing is possible because of disaggregation 
and, once disaggregated, there are few barriers to offshore process­
ing. Licensed (frequently dual-licensed), American-trained, and 
credentialed radiologists in Australia,174 Israel,175 and India all pro­
vide nighttime coverage for U.S. hospitals. For example, Ban­
galore-based Teleradiology Solutions uses HIPAA-compliant high­
speed connections to provide a "preliminary interpretation" of CT, 
MRI, conventional, and ultrasound scans within thirty minutes from 
when the scan takes place in the United Statesp6 The term "pre­
liminary interpretation" is used in large part because of the Centers 
for Medicare and Medicaid Services rule that, some emergency situ­
ations aside, Medicare does not reimburse for services furnished 
outside the United States.177 As a result, a domestic radiologist will 
(or should) submit a "final primary report" after subsequently ex­
169. Leo Anthony Celi et aI., The eICU: It's Not Just Telemedicine, 29 CRITICAL 
CARE MED. N183, N183-N184 (2001). 
170. For a description of the technologies in practice, see Celi, id. See Carolyn 
Thompson, 'EICU' Lets Doctors Monitor Many Patients, EWEEK, Jan. 3, 2005, available 
at 2005 WLNR 1943649 (Westlaw); Timothy J. Mullaney, The Doctor is (Plugged) In, 
Bus. WK., June 26, 2006, at 56, available at 2006 WLNR 10780096 (Westlaw). 
171. Sarah Lovinger, Beaming Images Overseas Sparks Controversy at Home, 
ACP OBSERVER, May 2006, available at http://www.acponline.orgljournals/news/may06/ 
outsource.htm. 
172. See, e.g., Marilyn J. Field & Jim Grigsby, Telemedicine and Remote Patient 
Monitoring, 288 JAMA 423, 424 (2002), available at http://jama.ama-assn.orglcgi/ 
reprint/288/4/423.pdf. 
173. Lovinger, supra note 171. 
174. Greg Gillespie, Down Under Image Readers Cover U.S. Radiologists, 
HEALTH DATA MOMT., July 1, 2005, at 16, available at 2005 WLNR 10362694 
(Westlaw). 
175. Erica Chernofsky, The View from Here, JERUSALEM POST (Isr.), Mar. 17, 
2006, at 22, available at 2006 WLNR 4799982 (Westlaw). 
176. See, e.g., Teleradiology Solutions, Interpretive Services, http://www.telradsol. 
com/services.htm (last visited Mar. 18, 2007). 
177. 42 C.F.R. § 411.9(a) (2006). Centers for Medicare & Medicaid Services 
(CMS) is currently reviewing aspects of this rule. Press Release, eMS, FY 2007 Hospi­
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amining the image,l78 However, additional state impediments to 
such arrangements, such as corporate practice and fee splitting, may 
not be so simply avoided.179 
C. Pharmaceutical Arbitrage 
There are several motives behind patient interest in "outsourc­
ing" access to pharmaceuticals. Worldwide, pharmaceutical compa­
nies practice price and distribution discrimination;180 the limited 
formularies of state-run health care systems and managed care or­
ganizations, or their Pharmacy Benefits Managers (PBMs), bar sub­
sidized access to some drugs, while underinsured patients (those 
with shallow coverage) increasingly cannot afford the "market 
price" of drugs prescribed for them. l81 Meanwhile, some outlying 
"patients" pursue controlled substances or lifestyle drugs that their 
doctors will not prescribe or that they are too embarrassed to 
request.182 
As a general rule, health care consumers or payers in the 
United States cannot legally acquire prescription drugs outside 
traditional domestic distribution channels.183 The FDA, citing the 
Food, Drug, and Cosmetic Act (FDCA),184 has taken the position 
that "gray-market" versions of an approved drug, and even U.S.­
tal Inpatient Prospective Payment System Proposed Rule (Apr. 12, 2006), available at 
http://www.cms.hhs.gov/apps/media/press/release.asp?Counter=1834. 
178. Wachter, supra note 165, at 662. 
179. See, e.g., Nicole Huberfeld, Be Not Afraid of Change: Time to Eliminate the 
Corporate Practice of Medicine Doctrine, 14 HEALTH MATRIX 243, 243-44 (2004). 
The modern version of the corporate practice of medicine doctrine derives 
from two principles: (1) any person that "practices medicine" must be licensed 
by the state in which she practices to provide medical services and (2) health 
care professionals cannot assist unlicensed persons or entities in practicing un­
licensed medicine, which prevents the splitting of professional fees with non­
professionals. 
Id. (citations omitted). 
180. Cf In re Canadian Import Antitrust Litigation, 470 F.3d 785, 791 (8th Cir. 
2006) ("The absence of competition from Canadian sources in the domestic prescription 
drug market, therefore, is caused by the federal statutory and regulatory scheme 
adopted by the United States government, not by the conduct of the defendants. Con­
sequently, the alleged conduct of the defendants did not cause an injury of the type that 
the antitrust laws were designed to remedy."). 
181. See, e.g., Milt Freudenheim, Drug Prices Up Sharply This Year, N.Y. TIMES, 
June 21, 2006, at C1, available at 2006 WLNR 10674943 (Westlaw) (discussing an 
AARP study that noted that the wholesale price of brand-name pharmaceuticals in­
creased 3.9 percent, four times the inflation rate during the first quarter of 2006). 
182. See Terry, Prescriptions sans Frontieres, supra note 62, at 222, 225. 
183. See generally id. 
184. Food, Drug, & Cosmetic Act, 21 U.S.c. § 355(a) (2000). 
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sourced reimported drugs, are unapproved because they do not 
comply with U.S. labeling and packaging requirements185 and con­
travene the monopoly on reimportation granted to U.S. 
manufacturers.186 
As is the case in most Western countries,187 an exception exists 
for those who enter the United States (including returning medical 
tourists) with personal supplies of prescription drugs. The Con­
trolled Substances Act (CSA)188 allows individuals to personally 
import a prescription drug "if: (1) the substance is found in one of 
the approved 'schedules,' (2) the substance is in its original 
container, (3) a declaration is made to the United States Customs 
Service, and (4) use of such substance is permitted by federal and 
state laws."189 "There is no personal importation exception in the 
FDCA. The FDA, however, has issued enforcement guidelines [for 
customs officers] that create a de facto exemption" where "'the 
quantity and purpose are clearly for personal use, and the product 
does not present an unreasonable risk to the user."'190 The CSA 
exemption clearly assumes that the drugs are in the possession of a 
traveler,191 while the FDA guidance implies the same by excluding 
commercial and promotional shipments. "The Guidance also states 
that non-commercial shipments generally include products that are: 
'personally carried, shipped by a personal non-commercial repre­
sentative of a co-signee, or shipped from [a] foreign medical center 
185. See generally 21 C.F.R. § 314.50 (2006) (listing drug application 
requirements). 
186. 21 U.S.c. § 381(d)(1) ("[N]o drug subject to section 353(b) of this title ... 
which is manufactured in a State and exported may be imported into the United States 
unless the drug is imported by the manufacturer of the drug."). 
187. See, e.g., Australian Gov., Therapeutic Goods Admin., Travellers Visiting 
Australia, Importing Medicines for Personal Use, http://www.tga.gov.au/docs/htmllbring 
med/intoaust.htm (last visited Mar. 18, 2007). 
188. Controlled Substances Act, 21 U.S.c. §§ 801-971 (2000). 
189. Terry, Prescriptions sans Frontieres, supra note 62, at 205 (citing 21 U.S.c. 
§ 956(a) (2000». The Controlled Substances Trafficking Prohibition Act of 1998 tight­
ened this exception, stating that a U.S. resident may not enter the United States 
through an international land border with more than fifty dosage units of a controlled 
substance unless the individual possesses a valid prescription issued by a practitioner in 
accordance with federal and state law. See id. (citing 21 U.S.c. § 956(a)(2». 
190. Terry, Prescriptions sans Frontieres, supra note 62, at 272 n.129 (quoting 
FDA, OFF. OF REGULATORY AFF., REGULATORY PROCEDURES MANUAL: CHAPTER 9, 
SUBCHAPER COVERAGE OF PERSONAL IMPORTATIONS (2006». Chapter 9 is currently 
under revision. 
191. 21 C.F.R. § 1301.26 (2006) ("Any individual who has in his/her possession a 
controlled substance ... may enter or depart the United States ...."). 
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where [a] person has undergone treatment."'192 Short-term "tour­
ists," frequently retirees on fixed incomes, who take bus rides over 
the Canadian or Mexican borders to buy their prescription 
medicines, routinely rely upon the CSA exemption and the FDA 
guidance.193 
U.S. patients in increasing numbers have looked to the In­
ternet to acquire "gray-market" drugs. The first generation of on­
line prescribing sites apparently featured licensed doctors who 
reviewed questionnaire-based histories before writing prescriptions 
that were then forwarded to associated pharmacy operations for 
mail-order fulfillment.194 In reality, most of these prescribing sites 
used contract ghostwriters of suspect licensure to rubber-stamp the 
prescriptions.195 Viewing a fight against online prescribing as part 
of the "war on drugs," U.S. states amended their physician licen­
sure rules to essentially outlaw this gray market196 by requiring a 
"traditional" or "proper" relationship between the prescribing phy­
sician and the patient designed to guarantee in-person contact or a 
"good faith prior examination."197 At the same time, federal and 
state authorities have become more rigorous in regulating the activ­
ities of online U.S. pharmacies.198 As a result and not surprisingly, 
the suppliers have moved offshore. No longer a "gray" area, the 
192. Terry, Prescriptions sans Frontieres, supra note 62, at 206-07 (quoting Marvin 
A. Blumberg, FDA, Information on the Importation of Drugs, Prepared by the Division 
of Import Operations and Policy, FDA (Apr. 3, 1998), http://www.fda.gov/ora/importl 
pipinfo.htm); see also FDA, OFF. OF REGULATORY AFF., REGULATORY PROCEDURES 
MANUAL: CHAPTER 9, SUBCHAPER COVERAGE OF PERSONAL IMPORTATIONS (2006), 
available at http://www.fda.gov/ora/compJiance_ref/rpm_new2/ch9pers.html. 
193. See, e.g., Alexander Colhoun, Get on the Bus: Extreme Answers to Prescrip­
tion Drug Costs, CHRISTIAN SCI. MONITOR, Apr. 18,2000, at 3, available at http://www. 
csmonitor.coml2000/0418/p3sl.html; Randi Hunter Epstein, Some Retirees Look 
Abroad for Prescription Drugs, N.Y. TIMES, Sept. 24, 2002, at FS, available at 2002 
WLNR 4068017 (Westlaw). 
194. See, e.g., State ex reI. Stovall v. ConfiMed.com, L.L.c., 38 P.3d 707 (Kan. 
2002) (prosecution of questionnaire-prescribing doctor following a state "sting" 
operation). 
19S. See, e.g., United States v. Nelson, 72 Fed. App'x 837 (10th Cir. 2003), affd, 
383 F.3d 1227 (10th Cir. 2004). 
196. See Terry, Prescriptions sans Frontieres, supra note 62, at 204. 
197. See, e.g., CAL. Bus. & PROF. CODE § 2242(a) (West 2006); ARIZ. REV. STAT. 
ANN. § 32-18S4 (West 2006). 
198. See, e.g., United States v. Rx Depot, Inc., 438 F.3d lOS2 (10th Cir. 2006); see 
also Bob Tedeschi, Pharmacies Endorse Crackdown on Fraud, N.Y. TiMES, Oct. 24, 
200S, at C4, available at 200S WLNR 17161884 (Westlaw) (noting the closing of 4,600 
illegal Internet pharmacy sites by federal drug investigators). 
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issue is now one of practical enforcement.199 Faced with millions of 
foreign-sourced drug shipments into the United States each year,2oo 
law enforcement has tried to slow the traffic with the help of credit 
card companies,201 shippers,202 and even Internet search engines.203 
The matter might have ended there had it not been for the 
quite unprecedented entry of several U.S. states into the gray mar­
ket enterprise. Numerous states and municipalities, concerned 
about prescription drug costs,2°4 have encouraged reimportation 
and petitioned the FDA for a waiver,205 or even set up their own 
reimportation plans.206 Throughout, the FDA has successfully de­
fended its policy before the federal courts207 and been resolute in its 
opposition to state reimportation initiatives. For example, in a 2006 
response to a waiver application from the State of Washington, the 
Agency stated: 
Granting a waiver that permits the importation of prescription 
drugs from Canada, U .K., Ireland, and other foreign countries 
will not only result in violations of federal law, but could also put 
Washington State citizens at risk. FDA approves a drug based on 
scientific data submitted by the drug sponsor to demonstrate that 
the drug is safe and effective. We cannot provide adequate assur­
199. See generally Prescription Drugs, Preliminary Observations on Efforts to En­
force the Prohibitions on Personal Importation: Hearing Before the S. Permanent Sub­
comm. on Investigations, Comm. on Governmental Affairs, 109th Congo (2004) 
(statement of Richard M. Stana, Dir., Homeland Security & Justice Issues), available at 
http://www.senate.gov/-govt-aff/_files/072204stana~a03494.pdf. 
200. See, e.g., A New Source for Discount Prescriptions, N.Y. TIMES, Dec. 26, 
2002, at A36, available at 2002 WLNR 4442939 (Westlaw). 
201. See, e.g., Gilbert M. Gaul & Mary Pat Flaherty, Firms Pressed on Internet 
Drugs; Senate Panel Writes to Credit Card Companies, Shippers, WASH. POST, Dec. 10, 
2003, at A4, available at LEXIS. 
202. See, e.g., Rick Brooks, FedEx and UPS Say They Shun Parcels Containing 
Illicit Drugs, WALL ST. J., Jan. 9, 2004, at AS, available at LEXIS. 
203. See, e.g., Gilbert M. Gaul & Mary Pat Flaherty, Google to Limit Some Drug 
Ads; Web Giants Asked to Help Discourage Illicit Online Pharmacies, WASH. POST, 
Dec. 1,2003, at AI, available at 2003 WLNR 5S0S635 (Westlaw). 
204. For examples of cost savings, see Cross-border Rx, CBC NEWS ONLINE, Jan. 
17, 2006, http://www.cbc.ca/news/background/drugs. 
205. See, e.g., STATE OF VT. AGENCY OF ADMIN., CITIZEN PETITION FOR WAIVER 
(2003), available at http://www.vermontpersonnel.orgiemployee/pdflFDAPetition120 
703.pdf. The FDA subsequently rejected the petition. Letter from William K. Hub­
bard, Assoc. Comm'r for Pol'y & Planning, FDA, to Michael K. Smith, Sec'y of Admin., 
State of Vt. (Aug. 4, 2004), available at http://www.vermontpersonnel.orglhtrnlpdflFDA 
Denial.pdf. 
206. See Terry, Prescriptions sans Frontieres, supra note 62, at 207-17. 
207. See, e.g., Andrews v. U.S. Dep't of Health & Human Servs., No. 04-0307, 
2005 U.S. Dist. LEXIS 5710 (D.D.C. Mar. 31,2005); Vermont v. Leavitt, 405 F. Supp. 
2d 466 (D. Vt. 2005). 
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ance to your constituents that the drug products delivered to 
them from foreign countries are the same products approved by 
FDA.208 
Undeterred and increasingly irritated with the federal govern­
ment,209 several states have persisted and jointly sponsor I-Save 
RX, a website developed by the governor of Illinois but now also 
serving residents of Wisconsin, Kansas, Missouri, and Vermont.210 
I-Save RX uses a Canadian PBM as an intermediary,211 and the 
PBM sources the drugs from pharmacies and wholesalers in Ca­
nada, Ireland, the United Kingdom, New Zealand, and Australia. 
The I-Save RX program only applies to prescription refills and ex­
cludes most controlled substances or drugs that require special han­
dling. Under the program, U.S. prescriptions and medical histories 
are forwarded to physicians in the supplying countries, apparently 
rewritten to comply with local laws, and dispensed by local, licensed 
pharmacists who then ship the medicine to the United States.212 
Pharmaceutical manufacturers have attempted to cut off for­
eign pharmacies by more rigorously controlling and policing their 
wholesale distribution.213 Not surprisingly, the FDA has targeted 
shipments into the United States by I-Save RX suppliers214 and, af­
ter lobbying by the United States, Canada's health minister has an­
nounced plans to increase regulation of the cross-border trade and 
to cut off bulk supplies to the United States.2IS Critics have even 
208. Letter from Randall W. Lutter, Assoc. Comm'r for Pol'y & Planning, FDA, 
to Steven M. Saxe, Dir., Wash. State Bd. of Pharmacy (Mar. 17, 2006), available at 
http://www.fda.gov/oc/opacom/hottopics/importdrugs/saxe031706.html. 
209. See, e.g., Vt. Dep't of Human Res., Tackling the Prescription Drug Crisis, 
http://www.vermontpersonnel.orglhtm/prescription.php (last visited Mar. 18, 2007). 
210. I-SaveRx, Welcome to I-SaveRx, http://www.i-saverx.net (last visited Mar. 
18,2007). 
211. CanaRx, Servs., Inc., CanaRx, http://www.canarx.com (last visited Mar. 18, 
2007). 
212. I-SaveRx, Frequently Asked Questions: Order Questions, http://www.i­
saverx.neUenrollment.htm (last visited Mar. 18, 2007). 
213. See, e.g., Mark Heinzl & Tamsin Carlisle, Canadian Pharmacies vs. Big Drug 
Makers-Online Retailers Vow to Fight Edict Seeking to Clamp Down on Cheap Ex­
ports to the U.S., WALL ST. J., Aug. 12,2003, at D4, available at LEXIS; Bernard Simon, 
Pfizer Moves To Try To Stop Drugs from Canada, N.Y. TIMES, Jan. 14,2004, at WI, 
available at 2004 WLNR 5507399 (Westlaw); Fearing End to Canada Drugs, States Now 
Look to Europe, USA TODAY, Jan. 14, 2005, available at http://www.usatoday.com/ 
newslhealthl2005-01-14-drugs-europe_x.h tm. 
214. FDA: Seizes Shipments Imported Through I-Save Rx Program, AM. HEALTH 
LINE, Mar. 10, 2005, available at LEXIS. 
215. Judith Graham, Canada to Ban Bulk Drug Exports, Allow Internet Sales, 
CHI. TRIB., June 30, 2005, at C7, available at 2005 WLNR 23487959 (Westlaw); cf Lisa 
Girion, Senate Votes to Ease Drug Imports, L.A. TIMES, July 12, 2006, at C1, available at 
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argued that the I-Save RX program creates confusion among con­
sumers facing enrollment in the new Medicare Part D216 low-cost 
drug plans.217 Notwithstanding, political pressure and consumer 
complaints have finally led the FDA away from seizing small pre­
scription shipments and to instead concentrate on larger shipments 
of illegal drugs.218 However, given adverse changes in the U.S.-Ca­
nada exchange rate,219 and the relatively small number of orders 
processed by I-Save RX (there are 27 million eligible residents, yet 
fewer than 20,000 orders were placed in its first two years of opera­
tion),220 it may be that the program now primarily functions as a 
political symbol. 
D. Clinical Trials 
In 2004, pharmaceutical companies spent nearly $39 billion on 
research and development. Twenty-one percent of this was spent 
outside the U.S. The outsourcing of clinical trials is a relatively new 
drug (and device) research and development (R&D) phenomenon 
led by the increasing importance of Contract Research Organiza­
tions (CROS).221 The major pharmaceutical companies predict that 
this outsourcing trend will continue in the near term, with 50-70 
percent of clinical trials soon to be performed outside the United 
States.222 
2006 WLNR 11980042 (Westlaw) (reporting 2006 House and Senate votes prohibiting 
customs seizures of prescription drugs imported or carried over the border by 
individuals). 
216. The Medicare Part D program was introduced by the Medicare Prescription 
Drug, Improvement, and Modernization Act of 2003, Pub. L. No. 108-173, 117 Stat. 
2066,2071. 
217. Mary Massingale, State Promotional Effort May Confuse Those Dazed by 
Medicare Part D, COPLEY NEWS SERV., Dec. 16,2005, available at Westlaw. 
218. U.S. to Stop Seizing Canadian Drug Imports; New Policy Allows Seniors to 
Order Cheaper Prescriptions Through the Mail, MSNBC.coM, Oct. 4, 2006, http://www. 
msnbc.msn.comlid/1S127747. 
219. Theresa Agovino, Savings/rom Canada Drug Purchasing Falls, ASSOCIATED 
PRESS, Jan. S, 200S (on file with the author). 
220. Richard A. Rettig, The Industrialization a/Clinical Research, HEALTH AFF., 
Mar.-Apr. 2000, at 129, 129-46, available at http://content.healthaffairs.orglcgi/reprint/ 
19/2/129.pdf; Massingale, supra note 217; see also Warren Wolfe, State's Seniors Buy 
Fewer Canadian Drugs, STAR TRIB. (Minneapolis-St. Paul), July 12,2006, at B2, avail­
able at 2006 WLNR 12097293 (Westlaw) (reporting that sales through the Minnesota 
RxConnect reimportation program have dropped to an all-time low). 
221. Rettig, supra note 220, at 129-46. 
222. Julie Schmit, Costs, Regulations Move More Drug Tests Outside USA, USA 
TODAY, May 16, 200S, available at http://www.usatoday.com/money/industrieslhealth/ 
drugs/200S-0S-16-drug-trials-usacx.h tm. 
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The growth of offshore trials is partly explicable by the oppor­
tunities that manufacturers now have for concurrent, rather than 
sequential (to use the U.S. term), New Drug Applications223 across 
several jurisdictions.224 It is also a function of dramatically lower 
offshore costs and, according to critics, a way for drug companies to 
distance themselves from U.S. regulatory scrutiny.225 
As with medical tourism, and stimulated by increasingly West­
friendly intellectual property laws,226 domestic and U.S.-owned 
CROs are blossoming in India.227 Trials are performed in India at 
40-60 percent of their cost in Western countries.228 A large cohort 
of English-speaking researchers, and a massive patient population 
with genetically distinct subsets, makes India a particularly attrac­
tive location.229 Offshore medical trials involving human subjects 
are also increasing in Thailand, Africa, China, and Latin America. 
In The Body Hunters, a series of articles published in The 
Washington Post in 2000, investigators detailed offshore human ex­
perimentation that was marred by inadequate, untranslated, or 
forged consents, deficient supervision by local ethics committees or 
FDA investigators, and medical care of participants that met only 
local, not U.S., standards.230 One such study investigated was Pfizer 
223. See FDA, Ctr. for Drug Evaluation & Research, New Drug Application 
(NDA) Process, http://www.fda.gov/cder/regulatory/applicationsINDA.htm (last visited 
Mar. 18, 2007). 
224. For example, lobbying from international pharmaceutical companies led In­
dia to remove the "phase lag" theretofore required by its Drugs and Cosmetics rules. 
See Samiran Nundy & Chandra M. Gulhati, A New Colonialism?-Conducting Clinical 
Trials in India, 352 NEW ENG. J. MED. 1633, 1633 (2005). 
225. Schmit, supra note 222. 
226. Gunjan Sinhu, Outsourcing Drug Work: Pharmaceuticals Ship R&D and 
Clinical Trials to India, SCI. AM., Aug. 16, 2004, at 24. 
227. K. S. Jayaraman, Outsourcing Clinical Trials to India Rash and Risky, Critics 
Warn, 10 NATURE MED. 440 (2004), available at http://www.pridco.com/english/media_ 
center/pdCproxy.php?pdUd=352. 
228. Id.; Sinhu, supra note 226. 
229. Jayaraman, supra note 227; see also Nundy & Gulhati, supra note 224, at 
1634. 
230. Joe Stevens, Where Profits and Lives Hang in Balance; Finding an Abun­
dance of Subjects and Lack of Oversight Abroad, Big Drug Companies Test Offshore to 
Speed Products to Market, WASH. POST, Dec. 17,2000, at AI, available at LEXIS; Mary 
Pat Flaherty et aI., Testing Tidal Wave Hits Overseas: On Distant Shores, Drug Firms 
Avoid Delays-and Scrutiny, WASH. POST, Dec. 18,2000, at AI, available at LEXIS; 
Estonia Parnu, The Dilemma: Submit or Suffer; 'Uninformed Consent' Is Rising Ethic of 
the Drug Test Boom, WASH. POST, Dec 19, 2000, at AI, available at LEXIS; John Pom­
fret & Deborah Nelson, An Isolated Region's Genetic Mother Lode; Harvard-Led Study 
Mined DNA Riches: Some Donors Say Promises Were Broken, WASH. POST, Dec. 20, 
2000, at AI, available at LEXIS; Karen DeYoung & Deborah Nelson, Latin America Is 
Ripe for Trials, and Fraud: Frantic Pace Could Overwhelm Controls, WASH. POST, Dec. 
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Inc.'s Nigerian trials of "Trovan,"231 an antibiotic, on children, re­
sulting in multiple deaths and injuries. A subsequent Nigerian gov­
ernment investigation reportedly concluded that the research was 
illegal, and, contrary to allegedly altered documentation, the re­
search had not been approved in advance by a Nigerian ethics com­
mittee.232 Lawsuits brought against Pfizer in U.S. federal courts for 
alleged violations of international law, specifically, the Nuremberg 
Code and the Declaration of Helsinki, were dismissed for lack of 
subject matter jurisdiction under, inter alia, the Alien Tort Stat­
ute233 and because of forum non conveniens,234 notwithstanding ev­
idence of severe deficiencies in parallel legal proceedings in 
Nigeria.235 The fictionalized account in The Constant Gardener 
may be the victims' only memorial.236 
The Common Rule237 applies to all federally funded research 
involving human subjects, wherever it takes place.238 As a result, 
Institutional Review Boards (IRBs)239 and other domestic safe­
21,2000, at AI, available at LEXIS; Mary Pat Flaherty & Doug Struck, Life by Luck of 
the Draw; In Third World Drug Tests, Some Subjects Go Untreated, WASH. POST, Dec. 
22, 2000, at AI, available at LEXIS. 
231. Trovan is the Pfizer brand name for trovafloxacin mesylate. 
232. Joe Stevens, Panel Faults Pfizer in '96 Clinical Trial in Nigeria; Unapproved 
Drug Tested on Children, WASH. POST, May 7,2006, at AI, available at LEXIS. 
233. 28 U.S.c. § 1350 (2000). 
234. Adamu v. Pfizer, Inc., 399 F. Supp. 2d 495, 504-06 (S.D.N.Y. 2005); Abdul­
lahi v. Pfizer, Inc., Nos. 12677, 12678 (WHP), 2005 U.S. Dist. LEXIS 16126, at *54 
(S.D.N.Y. Aug. 9, 2005). 
235. Abdullahi, 2005 U.S. Dist. LEXIS 16126, at *47-52. 
236. JOHN LE CARRE, THE CONSTANT GARDENER (2000); see also Marcia An­
gell, The Body Hunters, N.Y. REV. BOOKS, Oct. 6, 2005, at 23, 23-25 (reviewing THE 
CONSTANT GARDENER (Universal Pictures 2005) and discussing the overlap of fact and 
fiction). 
237. The Federal Policy for the Protection of Human Subjects, often referred to 
as the "Common Rule," has been adopted by seventeen federal agencies. It provides 
for human subject protection by conditioning such research on institutional assurances, 
institutional review board (IRB) review, and the informed consent of subjects. See, e.g., 
U.S. Dep't of Health & Human Servs., Off. for Human Research Prot., Policy Gui­
dance, Common Rule, http://www.hhs.gov/ohrp/policy/#common (last visited Mar. 18, 
2007). 
238. 45 C.F.R. § 46.101 (2005). 
239. The FDA describes the role of an IRB as follows: 
Under FDA regulations, an IRB is an appropriately constituted group 
that has been formally designated to review and monitor biomedical research 
involving human subjects. In accordance with FDA regulations, an IRB has 
the authority to approve, require modifications in (to secure approval), or dis­
approve research. This group review serves an important role in the protec­
tion of the rights and welfare of human research subjects. 
The purpose of IRB review is to assure, both in advance and by periodic 
review, that appropriate steps are taken to protect the rights and welfare of 
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guards apply.240 As Alice Page has noted, however, these safe­
guards are almost exclusively procedural and "provide no guidance 
to IRBs or researchers about how ethics should be used as a mecha­
nism for protecting human research subjects."241 
Non-government-funded research (such as that performed by 
pharmaceutical companies or CROs) is not subject to the Common 
Rule. However, research leading to a U.S. drug New Drug Appli­
cation or device Premarket Approval Application must be per­
formed in compliance with generally applicable FDA rules. U.S. 
clinical studies must be performed under a U.S. Investigational 
New Drug Application (IND) or an Investigational Device Exemp­
tion (IDE). Foreign-based research does not require an IND or 
IDE, but the research sponsors can choose to apply for one; there­
after, all U.S. safeguards should apply.242 
If the research is not performed under an IND or IDE, and 
involves foreign subjects, FDA rules require that the research is 
conducted in accordance with the ethical principles stated in the 
Declaration of Helsinki or local legal protections, whichever is 
greater.243 Federal European standards take a similar approach, in­
corporating Helsinki and other international norms.244 
In theory, therefore, offshore clinical trials are conditioned on 
similar qualitative and subject protections as U.S. trials. The differ­
ence, however, is in the level of inspection and scrutiny. For exam­
ple, serious questions have been raised about the adequacy of the 
medical infrastructure in India to support quality trials, the training 
humans participating as subjects in the research. To accomplish this purpose, 
IRBs use a group process to review research protocols and related materials 
(e.g., informed consent documents and investigator brochures) to ensure pro­
tection of the rights and welfare of human subjects of research. 
FDA, Guidance for Institutional Review Boards and Clinical Investigators, Frequently 
Asked Questions (1998), http://www.fda.gov/oc/ohrtlirbs/faqs.html. 
240. See, e.g., 4S C.F.R. § 46.103. If non-U.S. sites are involved, a Federalwide 
Assurance of compliance with the U.S. federal regulations is required. See U.S. Dep't 
of Health & Human Servs., Off. for Human Research Prot., Step-by-Step Instructions 
for Filing a Federalwide Assurance for International (Non-U.S.) Institutions (June 6, 
200S), http://www.hhs.gov/ohrp/humansubjects/assurance/ifilasuri.htm. 
241. Alice K. Page, Ethical Issues in International Biomedical Research: An Over­
view, 37 I. HEALTH L. 629,636 (2004). 
242. 21 C.F.R. §§ 312.120, 814.1S(a) (2006). 
243. 21 C.F.R. §§ 312.120(c)(1), 814.1S(b). See generally FDA, GUIDANCE FOR 
INDUSTRY: ACCEPTANCE OF FOREIGN CLINICAL STUDIES (2001), available at http:// 
www.fda.gov/cder/guidance/fstud.pdf. 
244. See, e.g., Commission Directive 200S/28, 200S 0.1. (L 091) 13, available at 
http://europa.eu.intieur-lex/lexiLexUriServ/LexUriServ.do?uri=CELEX:3200SL0028: 
EN:HTML. 
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of Indian researchers, the quantity and quality of Indian IRBs, and 
the local ethical standards (including informed-consent deficien­
cies) applied in dealing with subjects.245 In a 2001 report, which 
was triggered by The Body Hunters and confirmed the dramatic in­
crease in the number of offshore clinical trials, the U.S. Department 
of Health and Human Services' Office of Inspector General (OIG) 
found key differences in the scrutiny of offshore trials.246 Specifi­
cally, the OIG noted deficiencies in the FDA's tracking of non-IND 
trials, the absence of FDA inspection of foreign IRBs, the lack of 
any "attestation" requirement for non-IND investigators and a fail­
ure to enforce attestation for foreign-based INDs, and generalized 
staffing, political, and logistical deficiencies that challenged rigor­
ous FDA inspection of foreign research sites.247 
III. GLOBALIZATION, HEALTH MARKETS, AND 

REGULATORY DILEMMAS 

What can one conclude from this brief survey of medical tour­
ism and outsourcing? Tourists who seek to leverage more favorable 
socio-medical policies (such as assisted suicide), or outsourcers 
looking to avoid quality or public-health-related regulation (such as 
acquiring drugs without prescriptions), may, for now, be dismissed 
as outliers. Most of the other scenarios described above rotate 
around international or regional cost vectors. Western tourists 
travel internationally for cheaper procedures, while Europeans 
travel regionally to avoid price-related rationing in their states of 
residence. U.S. hospitals outsource patient and hospital services 
(such as HIT and imaging) in search of reduced professional labor 
costs or surplus professionals. Western pharmaceutical companies 
testing their drugs seek both lower cost subjects (a function of re­
duced regulatory scrutiny) and less expensive researchers. 
These cost-driven transfers are hardly surprising. The United 
States spends considerably more on health care than any other 
country, yet is below the Organisation for Economic Co-Operation 
and Development (OECD) median on service utilization.248 Ger­
245. Nundy & Gulhati, supra note 224, at 1634. 
246. U.S. DEP'T OF HEALTH & HUMAN SERVS., OFF. OF INSPECTOR GEN., THE 
GLOBALIZATION OF CLINICAL TRIALS 15-16 (2001), available at http://oig.hhs.gov/oeil 
reports/oei-01-00-00190. pdf. 
247. [d. at 6-14; see also Jennifer Kahn, A Nation of Guinea Pigs, WIRED MAG., 
Mar. 2006, available at http://www.wired.com/wired/archive/14.03/indiadrug.html. 
248. Cf MICHAEL F. CANNON & MICHAEL D. TANNER, HEALTHY COMPETITION: 
WHAT'S HOLDING BACK HEALTH CARE AND How TO FREE IT 18-25 (2005) (conceding 
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aId Anderson and colleagues concluded that the primary difference 
between the United States and the health care systems of other 
countries is much higher pricing in the former.249 They observed 
that the major reason for disparate pricing across national borders 
is the variable of "the degree to which [different countries] try to 
whittle away at the rent earned on the supply side through the crea­
tion of market power on the buy (monopsony) side of the mar­
ket."250 Thus, medical tourists and outsourcers (a perfect example 
is a U.S. state reimporting drugs from Canada) are in most cases 
seeking to leverage the vector between domestic and offshore levels 
of government intervention on the buy side. 
Anderson and colleagues also addressed the question of why 
the global health care market fails to diminish national differences 
in buy-side policies (and hence prices ).251 Their explanation was 
that health care features poorly functioning domestic markets and 
trade-limiting barriers between domestic markets.252 Most of the 
domestic market failures lie outside the scope of this Artic1e.253 
However, the growing traction of "consumer-directed" health care, 
the latest in a long line of attempts to cure America's runaway 
health care costs,254 is worth noting. Consumer Directed Health­
care Plans (CDHPs) have features such as high deductibles and 
work in tandem with personal Health Savings Accounts (HSAs)­
all apparently designed to reduce misaligned incentives inherent in 
U.S. health care (because of, it is argued, over-reliance on third-
that there is waste in the system due to, for example, government intervention, but 
arguing that high levels of spending are partly attributable to high income, elderly 
populations, beneficial technological advances, and that the United States outperforms 
other countries with regard to cancer patients and low-birth-weight infants). 
249. Gerard F. Anderson et aI., It's the Prices, Stupid: Why the United States is so 
Different from Other Countries, HEALTIl AFF., May-June 2003, at 89, 89-90, available at 
http://www.medscape.com!viewarticle/452954_1. 
250. Id. at 102; see also Reinhardt et aI., supra note 139, at 10-25. In the present 
U.S. market, it takes aggressive pressure on the buy-side to have even minimal effects 
on pricing. See Scott Hensley, Big Buyers Push for Steep Price Cuts From Drug Mak­
ers, WALL ST. J., June 22, 2006, at Bl, available at LEXIS. 
251. Anderson et aI., supra note 249. 
252. Id. at 101-02 ("[NJeither the goods and services nor all of the inputs that 
produce them are perfectly mobile across countries."). 
253. But see generally CANNON & TANNER, supra note 248. 
254. For a chronological treatment of attempts to cure health care costs including 
CDHPS, see Uwe E. Reinhardt, Churchill's Dictum and the Next New Thing in Ameri­
can Health Care, 38 Bus. ECON., July 2003, at 3. 
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party payment and decision-making)255 and to empower consumers 
to make "market decisions" about how "their" health care dollars 
will be spent.256 However, as related by Edward Larson and Marc 
Dettmann, preliminary indications are that HSAs "will have little 
impact on rising health care costs or shrinking health care ac­
cess."257 Nevertheless, if consumer-directed health care does prove 
effective, patients with unfettered access to low-cost foreign health 
care or heavily outsourced domestic health care may well spend 
"their" care dollars abroad.258 
A. Barriers to Health Care Trading 
At first sight, the number of tradable medical procedures ap­
pears to be relatively low. Self-evidently, the patient must be able 
to travel. But the pool of ambulatory patients has barely been 
tapped. In fact, the combination of tourism and outsourcing sug­
gests that the number of tradable medical events should increase. 
Even with an as yet unmet practical ceiling on tourism, the continu­
ing disaggregation of domestic care, coupled with outsourcing of 
many of its components (for example, offshoring of ICU monitor­
ing or radiology triaging), suggests that physical or practical barriers 
are not determinative. The question arises, therefore, whether 
there are other barriers to medical trading that either limit current 
activity or are likely to cap it in the future. 
1. Regulation and Trade Barriers 
Policymakers, legislators, and professionals have never shown 
much enthusiasm for a flat health care world, even within their own 
borders. For example, in Europe, the Treaty of Rome and its prog­
eny have left health care policy and financing as a matter primarily 
for the member states.259 Within the United States, the question of 
who would regulate physicians was answered as early as 1889, 
"when the Supreme Court denied a due-process challenge to a West 
Virginia medical practice act which required state licensure of phy­
255. See generally John V. Jacobi, After Managed Care: Gray Boxes, Tiers and 
Consumerism, 47 ST. LOUIS U. L.J. 397 (2003); Greg Scandlen, Consumer-Driven 
Health Care: Just a Tweak or a Revolution?, 24 HEALTH AFF. 1554 (2005). 
256. See CANNON & TANNER, supra note 248, at 66-73. 
257. Edward J. Larson & Marc Dettmann, The Impact of HSAs on Health Care 
Reform: Preliminary Results After One Year, 40 WAKE FOREST L. REV. 1087, 1123 
(2005). 
258. See Scandlen, supra note 255, at 1554, 1557. 
259. See, e.g., Germany v. Parliament, Case C-376/98, 2000 E.C.R. 1-08419 (invali­
dating pan-European tobacco advertising law). 
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sicians."26o Only relatively recently, and not universally,261 have 
national standards begun to prevail over local ones in malpractice 
cases.262 Even HIPAA's "national" standard of health care infor­
mation confidentiality is undercut by its partial preemption rule 
that favors "more stringent" state laws.263 
Somewhat ironically, health care's ignorance that there is a flat 
world has also been responsible for a relative dearth of legal rules 
explicitly designed to impede medical trading. Obviously, immigra­
tion rules limit the freedom of movement of highly trained medical 
specialists, creating a supply-side surplus in some less-industrialized 
countries. As a result, notwithstanding initiatives such as the J-1 
Visa Waiver program,264 developed countries have been unable to 
satisfy their demand for foreign-trained doctors, and more recently, 
for nurses.265 However, providers simply end-run this barrier with 
260. Terry, Prescriptions sans Frontieres, supra note 62, at 190 (citing Dent v. 
West Virginia, 129 U.S. 114, 122 (1889)). 
261. See, e.g., Estate of Hagedorn v. Peterson, 690 N.W.2d 84, 90 (Iowa 2004) 
(approving jury instruction using a variant of the locality rule). 
262. See, e.g., Morrison v. MacNamara, 407 A.2d 555, 565 (D.C. Cir. 1979); Hall 
v. Hilbun, 466 So.2d 856, 872 (Miss. 1985); Sheeley v. Mem'l Hosp., 710 A.2d 161, 167 
(R.I. 1998). 
263. 45 C.F.R. § 160.202 (2005); see, e.g., U.S. ex reI. Pogue v. Diabetes Treatment 
Ctrs. of Am., No. 99-3298,2004 U.S. Dist. LEXIS 21830, at *10 (D.D.C. May 17,2004); 
Nat'l Abortion Fed'n v. Ashcroft, No. 03 Civ. 8695 (RCC), 2004 U.S. Dist. LEXIS 4530, 
at *17 (S.D.N.Y. Mar. 18,2004). 
264. The Rural Initiative-J-1 Visa Waiver program, permits a U.S. Department 
of Health and Human Services/Immigration and Naturalization Service "waiver[] of 
[the] return-home requirement for foreign physicians who [have] trained in the United 
States" but who are prepared to stay and work in health professional shortage or medi­
cally underserved areas. Press Release, U.S. Dep't of Health & Human Servs., The 
Rural Initiative-J-1 Visa Waiver (Dec. 17,2002), available at http://www.hhs.gov/rural 
initiative/waiver.html. For information on the effectiveness of the program, see Foreign 
Physicians: Preliminary Findings on the Use of J-l Visa Waivers to Practice in Under­
served Areas: Hearing Before the Subcomm. on Immigration, Border Security and 
Claims of the H. Comm. on the Judiciary, 109th Congo (2006) (statement of Leslie G. 
Aronovitz, Dir., Health Care Issues, U.S. Gen. Accounting Off.), available at http:// 
www.gao.gov/new.items/d06773t.pdf. 
265. The supply of foreign trained nurses into the United States was robust (with 
12,000 to 14,000 annual green cards) until the backlog of 2005. Celia W. Dugger, U.S. 
Plan to Lure Nurses May Hurt Poor Nations, N.Y. TIMES, May 24, 2006, at AI, available 
at 2006 WLNR 8880889 (Westlaw). The Comprehensive Immigration Reform Act of 
2006 attempted to remedy this by removing the cap on the immigration of nurses for 
seven years. Comprehensive Immigration Reform Act of 2006, S. 2611, 109th Congo 
(2006); see Press Release, Sam Brownback, U.S. Sen., Brownback Comments on Immi­
gration Bill Passage (Mar. 27,2006), available at http://brownback.senate.gov/pressapp/ 
record.cfm?id=253170. However, the overall immigration package was unable to 
achieve House approval. See Adam Nagourney et aI., Bush's Immigration Plan Stalled 
As House G.O.P. Grew Anxious, N.Y. TIMES, June 25, 2006, at AI, available at 2006 
WLNR 10985951 (Westlaw). 
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outsourcing; immigration may be restricted, but there are minimal 
barriers to sending dis aggregated services (e.g., imaging) offshore 
to be processed by those same surplus professionals. 
Not surprisingly, some legal rules that impede interstate trade 
(e.g., licensure) will have the potential to create barriers to interna­
tional trade. Take, for example, teleradiology. As already noted, 
the preliminary report made by the non-U.S. radiologist should be 
followed, upon transmittal back to the United States, by a final re­
port from a domestic radiologist who has examined the image.266 
Domestic providers, possibly aware that local ethical and legal rules 
can be exploited for protectionist purposes, argue that the U.S. 
component frequently consists of no more than "ghosting."267 In 
May 2006, the American College of Radiology issued a practice 
statement on this issue, stating that: 
It is unethical and likely fraudulent for a physician who has not 
personally interpreted the images obtained in a radiologic exami­
nation to sign a report or to take attribution of an interpretation 
of that examination rendered by another physician in a manner 
that causes the reader of a report to believe that the signing radi­
ologist was the interpreter. This practice, known as ghost report­
ing, should be strictly prohibited.268 
The College also called for the outsourced interpreters to possess 
dual licensure (both in the place where the image was obtained and 
where interpreted), to be credentialed by the facility where the im­
age was obtained, to have valid malpractice coverage in the state 
where the image was obtained, and to submit to U.S. jurisdiction.269 
If tourism continues to increase apace, hospitals may join doc­
tors in looking nervously at the foreign competition. The contro­
versy surrounding domestic, physician-owned specialty hospitals 
that leverage the "whole hospital" exception to self-referral 
prohibitions270 may be predictive. These facilities allegedly cherry­
pick "easier" (and hence more profitable) patient referrals and 
266. See supra text accompanying notes 177-178. 
267. Stein, supra note 167 (describing "ghosting" as the practice of "radiology 
operations ... staffed with one or two U.S.-certified radiologists who approve reports 
prepared by less-qualified technicians"); see infra note 268 and accompanying text 
(describing "ghost reporting"). 
268. Am. Coll. of Radiology, Revised Statement on the Interpretation of Radiol­
ogy Images Outside the United States (May 2006), available at http://www.acr.orgls_acr/ 
doc.asp?CID=541&DID=24137. 
269. Id. 
270. Stark Regulations, 42 C.F.R. §§ 411, 424 (2005). 
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higher-margin Diagnosis-Related Groups.271 After extensive lob­
bying by traditional hospitals, the MMA272 introduced a since-ex­
tended moratorium on such hospitals.273 High-profit surgical 
procedures and the government research grants that rotate around 
them cross-subsidize routine and indigent care. At some point hos­
pitals may view medical-tourism centers as jeopardizing this busi­
ness model by skimming off their most profitable patients and seek 
protectionist regulation. 
Pharmaceutical companies possess an array of legal mecha­
nisms, national intellectual property laws being the most obvious, to 
impede pharmaceutical arbitrage. But, to find a public law barrier 
to the reimportation of drugs from Canada, the FDA had to dig 
deep into the minutiae of the FDCA and supplement it with a me­
dia-friendly "quality" argument.274 In fact, the FDA's interpreta­
tion of the FDCA likely is correct.275 The problem is that the 
agency's motives are suspect, determined less by genuine quality 
concerns and more by a desire to shore up a governmental policy 
opposed to any intervention in the pharmaceutical market. As Ke­
vin Outterson has observed, either pharmaceutical rents in the 
United States are supra-optimal, or the pharmaceutical industry has 
been less than transparent in their counter-arguments.276 The ad­
ministration readily accepted the MMA prohibition on buy-side in­
271. Medicare Prescription Drug, Improvement, and Modernization Act of 2003, 
Pub. L. No. 108-173, § 507,117 Stat. 2066, 2295 (amending 42 U.S.c. § 1395nn(d)(3» 
(Diagnosis-Related Groups); see, e.g., Am. Hosp. Directory, Medicare Prospective Pay­
ment System, http://www.ahd.comipps.html(last visited Mar. 18, 2007). See generally 
Phillip L. Ronning & Michael Nugent, Freestanding Heart Hospitals: Is the End Near?, 
HEALTHCARE FIN. MGMT., Sept. 2004, at 94. 
272. Medicare Prescription Drug, Improvement, and Modernization Act of 2003, 
§ 507. 
273. See generally Letter from A. Bruce Steinwald, Dir., Health Care, U.S. Gov't 
Accountability Off., to Charles Grassley, Chairman, and Max Baucus, Ranking Minor­
ity Member, S. Comm. on Finance (May 19, 2004), available at http://www.gao.gov/new. 
items/d05647r.pdf (discussing specialty hospitals and potential new facilities). 
274. See supra note 208 and accompanying text; see also U.S. GEN. ACCT. OFF., 
INTERNET PHARMACIES: SOME POSE SAFETY RISKS FOR CONSUMERS, REPORT TO THE 
CHAIRMAN, PERMANENT SUBCOMMITTEE ON INVESTIGATIONS, COMMITTEE ON Gov­
ERNMENTAL AFFAIRS, U.S. SENATE 13 (2004), available at http://www.gao.gov/new. 
items/d04820.pdf. 
275. See Andrews v. U.S. Dep't of Health & Human Servs., No. 04-0307 (JR), 
2005 U.S. Dist. LEXIS 5710 (D.D.C. Mar. 31, 2005); Vermont v. Leavitt, 405 F. Supp. 
2d 466 (D. Vt. 2005). 
276. Kevin Outterson, Pharmaceutical Arbitrage: Balancing Access and Innova­
tion in International Prescription Drug Markets,S YALE J. HEALTH POL'y L. & ETHICS 
193, 197 (2005). 
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tervention277 and has been equally steadfast in hindering the 
supply-side pressures that would come with reimportation. 
Some domestic regulations applicable to health care are explic­
itly extraterritorial. For example, the EU data directive extends its 
reach to offshore medical data processing,278 a position that created 
tensions with the United States until the adoption of a safe-harbor 
model.279 In contrast, HIPAA appears unaware of any transna­
tional issues. Notwithstanding, outsourcers and their offshore part­
ners will have to be aware of the occasional state regulation, such as 
California's identity-theft statute, which applies to anyone who 
"conducts business in California" and imposes a duty to disclose 
any security breach to affected California residents.28o 
Of course, protectionist legislation is often only one good inter­
national "episode" headline away from passage. In 2004, after me­
dia coverage of the rogue medical transcriber in Pakistan, 
Congressman Markey proposed the Personal Data Offshoring Pro­
tection Act, which provided for notification to the patient prior to 
offshore outsourcing and would have required the patient to opt-in 
before outsourcing to countries with low levels of protection.281 
Similar legislation282 passed in California but was vetoed by Gover­
nor Schwarzenegger.283 
277. 42 U.S.c. § 1395w-l11(i) (Supp. 2003) ("In order to promote competition ... 
and in carrying out this part ... the Secretary-(I) may not interfere with the negotia­
tions between drug manufacturers and pharmacies and PDP sponsors; and (2) may not 
require a particular formulary or institute a price structure for the reimbursement of 
covered part D drugs."). 
278. Council Directive 95/46 of 24 Oct. 1995 on the Protection of Individuals with 
Regard to the Processing of Personal Data and on the Free Movement of Such Data, 
arts. 25-26, 1995 OJ. (L 281) 31 (EC). 
279. U.S. Dep't of Commerce, Welcome to the Safe Harbor, http://www.export. 
gov/safeharbor/index.html (last visited Mar. 18, 2007). For a survey of different health 
information protective systems, see generally Nicolas P. Terry, Privacy and the Health 
Information Domain: Properties, Models and Unintended Results, 10 EUR. J. HEALTH L. 
223,228 (2003). See also EU, U.S. Reach Deal on Sharing Passenger Data from Trans­
Atlantic Flights, USA TODAY, Oct. 6, 2006, available at http://www.usatoday.comltravel/ 
news/2006-10-06-eu-us-flier-data_x.htm; Press Release, The Working Party, Press Re­
lease on the SWIFT Case, Following the Adoption of the Article 29 Working Party 
Opinion on the Processing of Personal Data by the Society for Worldwide Interbank 
Financial Telecommunication (SWIFT) (Nov. 23, 2006), available at http://ec.europa.eu/ 
justice_home/fsj/privacy/news/docsIPR_SwifCAffair_23_11_06_en.pdf. 
280. CAL. CIv. CODE § 1798.82(a) (West 2006). 
281. See, e.g., Personal Data Offshoring Protection Act of 2004, H.R. 4366, 108th 
Congo § 3 (2004). 
282. S. 1492,2003-2004 Sess. § 56.32(b) (Cal. 2004). 
283. John M. Hubbell & Mark Martin, Governor Vetoes Bills on Offshoring Jobs: 
Legislation Bans Foie Gras Starting in 2012, S.F. CHRON., Sept. 30, 2004, at Bl, available 
at 2004 WLNR 7621668 (Westlaw). 
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2. 	 Limitations on Coverage and the Politics of the 

Underinsured 

In a recent Health Affairs article, Aaditya Mattoo and 
Randeep Rathindran argue that the primary barrier to increased 
medical tourism from the United States is a lack of coverage under 
existing health insurance policies.284 They argue that the United 
States health care bill could be reduced by up to $2 billion per an­
num if policies provided a tourism option that included travel ex­
penses.285 Other than explicit protectionist policies by or impacts 
on government-funded health care (e.g., Medicare and Medicaid), 
the authors suggest that tourism coverage is not generally included 
because of indeterminacies associated with quality and liability ex­
posure, monitoring costs associated with distant providers, and pos­
sible oligopolistic behavior by insurers.286 
As already noted, some Western insurers are making modest 
entries into overseas fulfillment.287 With experience, some of these 
posited barriers may resolve. Near term, Western insurers and 
policymakers likely will use the threat of overseas fulfillment as a 
bargaining tool with domestic health care providers. In June 2006, 
the Senate Special Committee on Aging held hearings on medical 
tourism.288 The Committee heard testimony from a family member 
of a medical tourist, an employer, an insurer, a tourism intermedi­
ary, and a U.S. plastic surgeon.289 Many of the issues discussed 
herein surfaced in some manner. However, the overall tone of the 
proceedings had less to do with tourism per se and more to do with 
the costs of domestic care. For legislators, medical tourism as it 
currently exists may be an epiphenomenon; like the reimportation 
of drugs from Canada, it is less of an issue requiring regulatory ad­
justment and more of a wedge to insert into the debate over health 
care costs and the plight of the underinsured. That such a wedge 
can prove effective is illustrated by the contract between the Amish 
and Mennonite communities and the Lancaster Regional Center in 
Pennsylvania. Willing to pledge against malpractice claims, pay in 
284. Aaditya Mattoo & Randeep Rathindran, How Health Insurance Inhibits 
Trade in Health Care, 25 HEALTH AFF. 358, 360 (2006). 
285. Id. at 362. 
286. Id. at 364-66. 
287. See supra text accompanying note 37. 
288. The Globalization of Health Care: Can Medical Tourism Reduce Health Care 
Costs? Hearing Before the S. Special Comm. on Aging, 109th Congo (2006), available at 
http://aging.senate.govlhearing...detail.cfm ?id=270728&. 
289. Id. 
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cash, and contract for a limited number of health care services, the 
communities negotiated discounted flat-rate payments for the ser­
vices they required-their negotiations were informed by their ex­
periences with regular travel to Mexico for discounted health care 
services.29o 
3. Quality and Compensation Costs 
Considerable care is needed in assessing whether quality varia­
tions between health care systems are creating barriers to tradable 
procedures or offshore outsourcing. First, "quality" is a far more 
complex value than the simple absence of error. Second, inherent 
in framing the quality-barrier question is the danger of stereotyping 
the medical systems in less developed countries. Third, when prov­
iders in industrialized countries raise quality issues, their motives 
must be examined because of the danger that they may be driven by 
protectionism rather than concern for patient health. 
As to "quality," Uwe Reinhardt and colleagues291 note that na­
tional systems that control costs with rationing frequently do so by 
implicit or explicit reference to cost-effective outcomes (e.g., choos­
ing not to buy quality-adjusted life years, or QALYs, over a certain 
cost).292 Thus, a source country's definition of quality will create 
potential medical tourists out of those whose treatments fall on the 
wrong side of a QALY-cost threshold. Equally, a country that sets 
its QALY cutoff below its available resources will create health sur­
pluses that are then available to treat tourists. 
Quality of care issues have been raised by doctors in Germany 
regarding patients who avoided waiting lists for kidney transplants 
by visiting commercial transplantation centers in, for example, In­
dia or Pakistan. The patients then returned to Germany with 
problems based on substandard tissue matching practices that lead 
to higher mortality rates than with "domestic" transplants.293 Simi­
larly, a survey of Australian plastic surgeons noted complications in 
patients returning from inexpensive cosmetic surgery in Bangkok. 
Reported problems included "'hideous scarring' and infections in 
290. Joel Millman, How the Amish Drive Down Medical Costs, WALL ST. J., Feb. 
21, 2006, at Bl, available at LEXIS. 
291. Reinhardt et aI., supra note 139, at 13-15. 
292. Helmut L. Karcher, German Doctors Protest Against "Organ Tourism", 313 
BRIT. MED. J. 1282, 1282 (1996). For one critique, see generally John La Puma & Ed­
ward F. Lawlor, Quality-Adjusted Life-Years: Ethical Implications for Physicians and 
Policymakers, 263 JAMA 2917 (1990). 
293. Karcher, supra note 292, at 1282. 
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breast implants."294 One surveyed doctor labeled the procedures as 
"'surgical roulette.' "295 In June 2006, before a Senate committee, 
the president of the American Society of Plastic Surgeons testified, 
"We are all aware of cases, which are reported in the media and 
which confront some of my colleagues and other physicians, of pa­
tients returning to this country with disfigurement and nearly fatal 
infections associated with unaccredited hospitals and unlicensed 
providers."296 
The theoretical quality barrier to medical tourism (and to some 
lesser extent health care outsourcing) is that the patient may experi­
ence poorer health outcomes abroad and, in the event of a medical 
mishap, reduced legal outcomes (compensation). At this stage, 
there is simply no data with which to address this "quality" ques­
tion. For every story about the risks of medical tourism there are 
countervailing endorsements from satisfied patients297 or observa­
tions that the adverse event rate at the private, tourist-oriented In­
dian surgery centers is equivalent to the best U.S. facilities.298 
Certainly, medical tourists who suffer medical mishaps may 
have to encounter an unfamiliar legal system. For example, the po­
sition of the U.K. government, relying on case law that suggests the 
National Health Service does not have a non-delegable duty to its 
patients, is that medical tourists who go abroad for treatment under 
the El12 scheme must rely on remedies, as against the treating pro­
vider, offered by the courts of the place of treatment.299 It may be 
294. Warnings on Plastic Surgery Mistakes, THE AGE (Austl.), Jan. 17,2006, avail­
able at http://www.theage.com.au/newsfNationallWarnings-on-plastic-surgery-mistakesl 
2006/01l17/1137466979953.html (quoting Dr. Norm Olbourne); see also More Aus­
tralians Heading Overseas for Surgery (Austl. Broadcasting Corp. television broadcast, 
July 25, 2005) (transcript available at http://www.abc.net.aul7.30/content/2005/s1422042. 
htm) (discussing complications following knee surgery on an Australian patient in 
India). 
295. Warnings on Plastic Surgery Mistakes, supra note 294 (quoting Dr. Norm 
Olbourne). 
296. The Globalization of Health Care: Can Medical Tourism Reduce Health Care 
Costs? Hearing Before the S. Special Comm. on Aging, 109th Congo (2006) (statement 
of Bruce Cunningham, Am. Soc'y of Plastic Surgeons), available at http://aging.senate. 
gov/eventslhrI59bc.pdf. 
297. See, e.g., The Globalization of Health Care: Can Medical Tourism Reduce 
Health Care Costs? Hearing Before the S. Special Comm. on Aging, 109th Congo (2006) 
(statement of Maggi Ann Grace, patient and patient advocate), available at http://aging. 
senate.gov/eventslhrI59mg.pdf. 
298. John Lancaster, Surgeries, Side Trips for 'Medical Tourists'; Affordable Care 
at India's Private Hospitals Draws Growing Number of Foreigners, WASH. POST, Oct. 
21, 2004, at AI, available at LEXIS. 
299. Cara Guthrie & Hannah Volpe, Overseas Treatment for NHS Patients, 2006 
J. PERS. INJ. L. 12, 15-16. 
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the case that the dramatically lower costs of care in, say, India, are a 
function of that country's lower malpractice recovery300 and lower 
malpractice insurance costs,301 although that canard has been ex­
posed regarding U.S. health care.302 Injured tourists returning to 
the United States, or domestic patients who, for some reason, can­
not establish liability against the local arm of their offshore pro­
vider, undoubtedly will face legal complications, such as jurisdiction 
and enforcement, in excess of those that would occur in a purely 
domestic setting.303 
Currently, the most likely barrier is information costs regard­
ing quality. There are indeterminacies and, hence, substantial in­
formation costs relating to the quality of offshore health and legal 
services.304 U.S. companies offshoring their HIT and disaggregated 
services can protect their interests with appropriate contractual, ju­
risdictional, and choice-of-Iaw provisions, much as they are com­
pelled to protect their patients by "exporting" HIPAA 
confidentiality and security requirements through "business associ­
ate" agreements.305 After the two reported extortion cases, tran­
scription service agreements now include much stronger controls on 
subcontracting.306 Western providers are also likely to face fewer 
legal problems when they use nearshoring because of the more 
closely aligned legal cultures and clearer bilateral dispute resolution 
practices. 
Medical tourists, however, face far higher information costs. 
Here, two scenarios suggest themselves. Either medical tourism 
will continue unabated with the vast majority of patients encounter­
ing no serious medical or legal adverse events, or quality disparities 
300. Garud, supra note 4, at 319. 
301. Lancaster, supra note 298. 
302. See MICHELLE M. MELLO, ROBERT WOOD JOHNSON FOUND., UNDER­
STANDING MEDICAL MALPRACTICE INSURANCE: A PRIMER (2006), available at http:// 
www.rwjf.org/publications/synthesis/reports_and_briefsIpdf/no8_primer.pdf. 
303. See, e.g., McLean, supra note 58, at 247-55; Nathanial H. Hwang, You've Got 
Mail-The Concerns of Electronically Outsourcing Radiological Services Overseas, 25 J. 
LEG. MED. 469, 477-83 (2004). 
304. Wachter, supra note 165, at 663-64. 
305. See, e.g., Sarah E. Hazelwood et a!., Possibilities and Pitfalls of Outsourcing, 
HEALTHCARE FIN. MGMT., Oct. 2005, at 44,45-46, available at http://www.findartic1es. 
com/p/artic1es/mi_m3257/is_10_59/ai_n15777189. 
306. BiIl Briggs, Offshore Outsourcing Poses Risks, HEALTH DATA MGMT., Feb. 
2005, at 68, available at http://healthdatamanagement.com/html/currentlPastIssueStory. 
cfm? Artic1eId=10505&issuedate=2005-02-01. For risk management strategies, see gen­
erally Margaret Davino, Assessing Privacy Risk in Outsourcing, 75 J. AHIMA 42 
(2004), available at http://library.ahima.orglxpedio/groups/public/documents/ahimalbok 
1_022546.hcsp?dDocName=bok1_022546. 
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will become a real or perceived barrier to tradable services. The 
latter may prove to be the case with U.S. patients who have come to 
rely on increasingly robust information about the quality of their 
domestic providers, due to the report cards, outcomes reports, and 
other data that Kristin Madison usefully describes as the products 
of "market-facilitating regulation."307 If this group of potential 
tourists steps back from foreign medical systems, their health insur­
ers (if involved) or tourism intermediaries will have an incentive to 
intervene and to demand quality comparability guarantees for their 
customers. They may refuse to contract with offshore providers 
that are not accredited by, say, Joint Commission InternationaP08 
or may themselves provide insurance packages ensuring coverage 
for offshore litigation or domestic remedial medical care. A paral­
lel dynamic may emerge in the legal systems of tourist destinations. 
While some underdeveloped countries may shore up their health 
quality and compensation systems (as is already occurring in the 
area of health data protection) to forestall protectionist regulation, 
others may join a "race to the bottom" to better compete for tour­
ists' hard currencies. 
B. Globalization and Free Trade 
"Globalization" is one of our fledgling century's "magic" 
words. It is also one that can mean different things to different peo­
ple, including "economic liberalization" or "global integration."309 
It is used here, and applied to health care, to denote the "increasing 
interconnectedness of people and places";310 a connectedness that 
"undermine[s] the importance of local and even national bounda­
ries in many arenas of human endeavor."311 
307. Kristin Madison, Regulating Health Care Quality in an Information Age, 40 
v.c. DAVIS L. REv. (forthcoming 2007). 
308. Joint Comm'n Int'l, About Joint Commission International, http://www.joint 
commissioninternational.com/22758 (last visited Mar. 18, 2007); see also Mattoo & 
Rathindran, supra note 284, at 366 (urging foreign providers to signal quality by passing 
U.S. licensing examinations); Lee Hui Chieh, US Quality Controls for Hospitals in 
S'pore, Aim Is to Improve Healthcare Quality and Boost Medical Hub Status, STRAITS 
TIMES (Sing.), Nov. 2, 2005, available at 2005 WLNR 17712514 (Westlaw) (detailing 
Joint Commission International accreditation of Singapore hospitals). 
309. See, e.g., William Scheuerman, Globalization, in STANFORD ENCYCLOPEDIA 
OF PHILOSOPHY (2006), http://plato.stanford.edu/entries/globalization;Globalization,in 
WIKIPEDIA, http://en.wikipedia.org/wiki/Globalization (last visited Mar. 18, 2007). 
310. Roy Smith, Access to Healthcare via Telehealth: Experiences from the Pacific, 
3 PERSP. ON GLOBAL DEV. & TECH. 197, 198 (2004). 
311. Scheuerman, supra note 309. 
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For health care, globalization can have both positive and nega­
tive connotations. The positives are obvious. For example, public 
health improves because improved communications increases ac­
cess and the speed of access to worldwide research and alarms 
about health threats.312 The negative correlate is that the increased 
personal interconnectedness of people increases the global impact 
of public health threats, for example the SARS epidemic in 2003 or 
bioterrorism.313 
International and regional trade agreements have had little im­
pact on core U.S. health care delivery compared, for example, to 
impacts on environmental law and policy. In the long term this may 
change. The General Agreement on Trade in Services (GATSpI4 is 
likely to increase cross-border trading of services and, as a result, 
stimulate cross-border recognition of professional licensure. In 
contrast, the Agreement on Trade-Related Aspects of Intellectual 
Property Rights (TRIPSpls has the potential to negatively affect 
some cross-border trade such as the reimportation of U.S.-pro­
duced pharmaceuticals.316 Other regional agreements such as the 
Central America Free Trade Agreement (CAFTA)317 likely will 
have similar impacts, both positive and negative.318 
312. Laura J. Nosek, Globalization's Costs to Healthcare: How Can We Pay the 
Bill?, NURSING ADMIN. Q., Apr.-June 2004, at 116, 116-17. 
313. Id. at 117-18; see also Nicholas Bakalar, Speed of the Spread of Flu is Linked 
to Airline Travel, N.Y. TIMES, Sept. 12,2006, at F9, available at 2006 WLNR 15784725 
(Westlaw). See generally Roy L. Simpson, Global Informing: Impact and Implications 
of Technology in a Global Marketplace, NURSING ADMIN. Q., Apr.-June 2004, at 144, 
147. 
314. See generally World Trade Org., General Agreement on Trade in Services 
(GATS), Annex lB, 33 I.L.M. 1125, 1167 (1994) [hereinafter "GATS"), available at 
http://www.wto.org/english/docs_e/legal_e/26-gats.pdf. 
315. See generally World Trade Org., Agreement on Trade-Related Aspects of 
Intellectual Property Rights (TRIPS), Annex IC, 33 I.L.M. 1197 (1994), available at 
http://www.wto.org/english/docs_e/legaLe/27-trips.pdf. 
316. See generally Ellen R. Shaffer et aI., Global Trade and Public Health, 95 AM. 
J. PUB. HEALTH 23 (2005). 
317. See generally U.S. Dep't of Agric., Foreign Agric. Serv., U.S.-Dominican Re­
public-Central America Free Trade Agreement (CAFTA-DR), available at http://www. 
fas.usda.gov/itp/CAFTAIcafta.asp (last visited Mar. 16, 2007). 
318. For services, see OFF. OF THE U.S. TRADE REPRESENTATIVE, CAFTA IS 
NOT "ANTI-DENTIST"-STATE LICENSING REQUIREMENTS NOT AFFECTED (2005), 
available at http://www.ustr.gov/assetslTrade_Agreements/BilateraIlCAFTAIBriefin~ 
Book/asset_upload_file876_7881.pdf. For pharmaceuticals, see OFF. OF THE U.S. 
TRADE REPRESENTATIVE, CAFTA AND ACCESS TO MEDICINES (2005), available at 
http://www.ustr.gov/assetslTrade_Agreements/BilateraIlCAFTA/Briefin~Book/assec 
upload_file433_7198.pdf. 
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The World Bank views globalization as the "[f]reedom and 
ability of individuals and firms to initiate voluntary economic trans­
actions with residents of other countries. "319 But the implications 
of agreements like GATS, for example, on national health care sys­
tems are still unclear. The agreement is subject to ongoing negotia­
tions and specifically based on commitments and exceptions 
scheduled by participating nations. In general terms, GATS calls 
for liberalization in the trade of services.32o According to Richard 
D. Smith321 and Ian S. Mutchnick and colleagues,322 services323 
likely to be liberalized include telehealth, medical tourism, foreign 
investment in domestic health care businesses, and the temporary 
movement across borders by health care workers. Smith suggests 
that, at this stage in the development of GATS, direct investment 
creating a foreign "commercial presence" is the "most critical."324 
So far, examples of U.S. participation in establishing a global 
health market have tended toward the embarrassing. For example, 
the United States has taken the position that foreign price controls 
result in U.S. consumers paying a disproportionate share of phar­
maceutical R&D costS.325 And in recent trade negotiations with 
Australia, the United States leveraged access to its agricultural mar­
ket to gain concessions from Australia on its domestic pharmaceuti­
cal price controls.326 For many Western countries, health care 
"globalization" has been little more than a process for securing ac­
cess to underdeveloped economies for their capital and health care 
services, coupled with ensuring worldwide patent protection for 
their pharmaceutical industries.327 
319. BRANKO MILANOVIC, CAN WE DISCERN THE EFFECT OF GLOBALIZATION 
ON INCOME DISTRIBUTION? EVIDENCE FROM HOUSEHOLD SURVEYS 6 (2004), available 
at http://www . worldbank.org/research/ineq uality/pdf/G LOB E8.pdf. 
320. GATS, supra note 314, at 1168 (preamble). 
321. Richard D. Smith, Foreign Direct Investment and Trade in Health Services: A 
Review of the Literature, S9 Soc. SCI. & MED. 2313, 2314 (2004). 
322. Ian S. Mutchnick et aI., Trading Health Services Across Borders: GATS, Mar­
kets, And Caveats, HEALTH AFF., Jan. 2S, 200S, at WS-42, WS-4S, WS-47, available at 
http://content.healthaffairs.orglcgi/reprin tlhlthaff. wS.42v1. pdf. 
323. GATS, supra note 314, at 1169 (art. I, 2). 
324. Smith, supra note 321, at 2318. 

32S. Reinhardt et aI., supra note 139, at 17-18. 

326. See generally Bob Burton, Australian Drug Pricing Scheme Under Pressure 
in Free Trade Talks, 328 BRIT. MED. J. 247 (2004); Bob Burton, Australia Makes Con­
cessions on Drug Approvals After US Pressure, 328 BRIT. MED. J. 42S (2004). 
327. See generally Press Release, Doctors Without BorderslMedecins Sans 
Frontieres, As WHO and UNAIDS Call For Global Treatment Scale-Up, MSF Asks: 
Where Will the Essential Drugs Come From? (Mar. 28, 2006), available at http://www. 
doctorswithoutborders.orglpr/2006/03-28-2006.cfm. 
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C. Non-Market Constraints and Regulatory Dilemmas 
Protectionism aside, today it is difficult to make a case for in­
creased regulation of medical tourism, outsourcing, or arbitrage. In 
the absence of negative evidence (for example, that medical tour­
ism increases domestic health care costs because of required do­
mestic remedial or follow-up treatments),328 it is arguable that 
foreign-sourced, low-cost, high-quality care will stimulate global 
health care and reduce the market failures seen in Western systems. 
But the preceding discussion assumes a Western frame-for exam­
ple, whether offshore clinical trials are a safe basis for U.S. drug 
approval, or whether U.S. health data processed abroad retains in­
tegrity. What has not been discussed is the impact on developing 
countries of some of this tourist or offshoring activity.329 
When Atul Gawande spent time in the hospitals of his family's 
homeland he noted the relative helplessness of Indian health care in 
the face of rapidly changing demographics-in particular, the rising 
life expectancy of its patient population. He also was struck by the 
contrast between poorly resourced and otherwise inadequate public 
health care facilities and the high-quality private facilities that cater 
to self-payers and medical tourists.33o Although India spends 5.1 
percent of its GDP on health care, less than 1 percent is spent on 
public sector health.331 Meanwhile, many Indian doctors view emi­
gration or, at least, residencies in Western countries, as major and 
realistic goals,332 significantly reducing the number of physicians in 
domestic practice.333 Not surprisingly, commentators in less-devel­
328. See, e.g., Amelia Gentleman, Our Baby Joy, by Test- Tube Tourists who Flew 
to India: Britons Risked Fury of Health Professionals at Home to Have Banned Multi­
Embryo Implant, OBSERVER (U.K.), Mar. 26, 2006, available at 2006 WLNR 5055044 
(Westlaw) (reporting objections to foreign IVF procedures counter-indicated in the 
U.K. on the basis that the National Health Service will bear the cost of potentially 
difficult multiple births and post-natal care). 
329. The issue also has been raised in trade between industrialized countries. For 
example, some Canadian patient advocacy groups oppose the Canada-U.S. drug trade 
because of the impact on drug supplies and prices for Canadian patients. Canadian 
Groups Ask for Ban on Web Pharmacies, crV.CA, Mar. 31 2004, http://www.ctv.ca/ 
servletl ArticleN ews/story/CTVNewsll 080740165689_67. 
330. Atul Gawande, Dispatch from India, 349 NEW ENG. J. MED. 2383, 2383-86 
(2003). 
331. Id. at 2386; Fitzhugh Mullan, Doctors for the World: Indian Physician Emi­
gration, 25 HEALTH AFF. 380, 382 (2006). 
332. Gawande, supra note 330, at 2386. 
333. Fitzhugh Mullan, The Metrics of the Physician Brain Drain, 353 NEW ENG. J. 
MED. 1810, 1818 (2005), available at http://content.nejm.orglcgi/reprint/353/17/181O.pdf; 
see also Christophe Segouin et aI., Editorial, Globalization in Health Care: Is Interna­
tional Standardization of Quality a Step Toward Outsourcing?, 17 INT. J. QUALITY 
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oped countries have questioned the impact of large numbers of 
medical tourists (in reality a form of medical colonialism) on the 
waiting lists for treatments for their own citizens.334 
Similar issues arise with regard to clinical trials. The Western 
philosophy behind trials involving human subjects is that they are 
an expression of altruism-a few volunteering now for trials to later 
benefit the many if the drug proves beneficial. This seems to be a 
flawed concept when applied to offshore clinical trials. The practi­
cal truth is that medically deprived patients in less-developed coun­
tries are going to enter such trials in the hope that their personal 
health future will benefit,335 Further, medicines tested in less-de­
veloped countries often are designed for, or at least initially des­
tined for, industrialized populations. At the very least, the 
populations that participate in the trials should be guaranteed par­
ticipation in any benefit and at an affordable price. 
The dilemma, of course, is that at a macro level, less-developed 
countries are looking to health tourists and outsourcing as ways to . 
grow their health care and HIT economies. Their citizens may view 
apparently beneficent but foreign regulation of activities in their 
countries as examples of legal colonialism, as no less protectionist 
than outright legal impediments to travel or offshoring. 
CONCLUSION 
The health care systems of the United States and other West­
ern countries face physician and nursing shortages; spiraling domes­
tic health care costs; the attraction of pharmaceutical arbitrage; the 
growing importance of portable, border-agnostic HIT; and possible 
increases in discretionary patient spending because of consumer-di­
rected health care. These factors suggest that medical tourism and 
health care outsourcing will expand in the near future. Given con­
cerns about health quality and data protection, it is perhaps surpris­
ing that these phenomena are essentially unregulated. 
Of the few legal obstructions to tourism that do exist, most are 
transitional, as regional systems such as the European Union dis­
mantle remaining interstate barriers. Outsourcing is essentially un­
regulated and is likely to remain that way. While international and 
HEALTH CARE 277, 277-79 (2005). A similar phenomenon applies to domestic nursing 
populations when developed countries liberalize their immigration policies. See, e.g., 
Dugger, supra note 265. 
334. Swati Bhattacharjee, Noor Fatima and Medical Tourism, 101 J. INDIAN MED. 
ASS'N 497, 497 (2003); Garud, supra note 4, at 319. 
335. See Kahn, supra note 247. 
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regional trade agreements have not noticeably accelerated tourism 
or outsourcing, they will impede outwardly protectionist regulation 
or legislation proposed in knee-jerk reaction to isolated media re­
ports of adverse events suffered by tourists or offshore data 
mishaps. 
In considering whether these phenomena are sub-optimally 
regulated, a variety of transnational or potentially transnational 
health care incidents can be written off as outliers. Thus, we can 
probably leave for another day the questions about how our regula­
tory systems should react to a used pacemaker being sold on an 
online auction site,336 international robotic surgery,337 or even on­
line organ matching.338 Of the areas where more robust patient 
protections are necessary, the most obvious is in data protection 
and, specifically, ensuring both that offshore data extenders are 
covered by U.S. confidentiality and security rules, and that enforce­
ment of those rules is effective. Here, however, the U.S. legal defi­
ciency may be less a function of an offshore location and more of 
the general inadequacies of the current medical privacy and confi­
dentiality protections.339 If the political will can be found to revisit 
medical privacy and confidentiality, then its extraterritorial effect 
should be made explicit. Other, perhaps less pressing issues, such 
as real or perceived quality deficiencies, are likely to be met near­
term with self-regulatory "patches," such as codes of conduct and 
accreditation. 
Over the long term it is difficult to see a truly global health 
care market replete with effective transnational patient-protective 
laws. As a result, there may come a time when domestic legal sys­
tems will be forced to address some of the issues raised here. When 
that time comes, it is imperative that U.S. regulation is sensitive to 
336. See Jennifer Ryan, Pirated Pacemaker Exposes Failings, E. V ALLEY TRIB. 
(Phoenix), Mar. 20, 2005, available at http://www.eastvalleytribune.com/index.php?sty= 
38232 (noting the sale of stolen pacemakers on e8ay, one of which was implanted into a 
patient in Arizona). 
337. McLean, supra note 58, at 243-45; cf J. Paul Finn et aI., M R Imaging with 
Remote Control: Feasibility Study in Cardiovascular Disease, 241 RADIOLOGY 528, 528­
37 (2006). 
338. See, e.g., MatchingDonors, http://www.matchingdonors.com (last visited 
Mar. 18, 2007) (connecting organ donors with patients in need). See generally Joyce 
Howard Price, Organ Donors Matched Online, WASH. TIMES, June 11, 2006, at A02, 
available at 2006 WLNR 10051388 (Westlaw); Pakistan 'Kidney Bazaar' Thrives, 
CNN.cOM, Nov. 17,2006 (on file with Western New England Law Review). 
339. See generally Terry & Francis, Ensuring the Privacy and Confidentiality of 
Electronic Health Records, supra note 154. 
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the domestic economies and policies of our trading partners. To 
avoid accusations of legal colonialism, we need to commence a dia­
logue as to how best to achieve any future regulation. 
